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ABSTRACT  
Lisa C. Vinikoor 
Trans Fatty Acid Intake and its Association with Adenomas and Cancers  
of the Colon and Rectum 
(Under the direction of Robert S. Sandler) 
 
 Recently, there has been increasing concern about the health effects of trans fatty 
acid consumption, however, little is known about its role in digestive tract neoplasia.  The 
goal of this dissertation was to investigate this relationship.   
 The association between trans fatty acid consumption and colorectal adenomas 
(present throughout the entire colon and rectum) was investigated using the Diet and Health 
Study IV, a cross-sectional study conducted between 2001 and 2002.  The highest quartile of 
consumption was associated with an increased prevalence of colorectal adenomas, with an 
adjusted prevalence odds ratio comparing the highest to the lowest quartile of consumption 
of 1.86 (95%CI 1.04, 3.33).   
 The North Carolina Colon Cancer Study I, a case-control study taking place between 
1996 and 2000, was utilized to examine the association for colon cancer (located between 
the cecum and sigmoid colon).  No association was seen between trans fatty acid 
consumption and colon cancer among Whites or African Americans.  Those in the highest 
quartile of consumption had an adjusted odds ratio of 1.01 (95%CI 0.69, 1.49) for Whites 
and 0.99 (95%CI 0.61, 1.62) for African Americans when compared to participants in the 
lowest quartile. 
 iii 
 The North Carolina Colon Cancer Study II was similar to the above study except 
cases of distal colorectal cancer (present in the sigmoid colon, rectosigmoid, and rectum) 
were recruited from 2001-2006.  An association was seen between trans fatty acid 
consumption and distal colorectal cancer in Whites, giving an adjusted odds ratio of 1.34 
(95%CI 0.99, 1.83) for the comparison of the highest quartile of consumption to the lowest.  
For African Americans this adjusted odds ratio was 0.54 (95%CI 0.28, 1.02).   
 In sum, the research presented in this dissertation demonstrated that high trans fatty 
acid consumption was positively associated with colorectal adenomas and cancers of the 
sigmoid colon, rectosigmoid, and rectum (in Whites).  No association was present between 
consumption and cancers of the colon (cecum through sigmoid colon).  Although further 
research needs to be done investigating the relationship for distal colorectal cancer in 
African Americans, as trans fatty acid consumption declines in the United States, rates of 
colorectal cancer may fall as well.   
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1. REVIEW OF THE LITERATURE 
 
1.1 SUMMARY 
 
Colorectal cancer is one of the most common cancers in the United States.  Diet, a 
key component of the environment, is a risk factor for colorectal cancer.  Total dietary 
fatty acid has not been demonstrated to be associated with colorectal cancer.  It is 
possible, however, that a specific type of dietary fatty acid is associated with colorectal 
cancer.  In this dissertation I hypothesize that trans fatty acid is positively associated with 
colon and rectal neoplasia.  This chapter begins with a review of colorectal cancer.  It 
continues with a discussion of fatty acids and trans fatty acids, including postulated 
biologic mechanisms for the trans fatty acid and colorectal cancer/adenoma relationship.  
This chapter concludes with a review of the current literature examining the association 
between trans fatty acids and colorectal cancer/adenomas and their limitations. 
.   
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1.2 BACKGROUND AND SIGNIFICANCE 
 
1.2.1 COLORECTAL CANCER 
 
A. DESCRIPTIVE EPIDEMIOLOGY 
 Colorectal cancer (hereafter defined as cancer present throughout the entire colon 
and rectum, unless otherwise specified) is the third most common cancer in the United 
States.  It has the third highest mortality rate, accounting for approximately 10% of all 
cancer deaths.  An estimated 112,340 people were diagnosed with colon cancer and 41,420 
people were diagnosed with rectal cancer in the United States in 2007.  An estimated 52,180 
deaths resulted from colorectal cancer this year (1).  Colorectal cancer is diagnosed later in 
life, with approximately 67% of the diagnoses occurring after age 64.  SEER, the 
Surveillance Epidemiology and End Results Program of the National Cancer Institute, 
reports an overall 5-year relative survival rate of 64.1% (2).  
 There is a disparity in both the incidence and mortality rates for colorectal cancer 
between Whites and African Americans.  The colorectal cancer incidence rate for African 
American men is 70.2/100,000 compared with 63.7/100,000 for White men.  The rates for 
women are 53.5/100,000 and 45.9/100,000, respectively.  Among men, the disparity is 
greater for mortality (33.6 compared to 23.7/100,000) (1).   
 
B. ADENOMA-CARCINOMA SEQUENCE  
 Colorectal cancer arises from a series of easily recognizable pathological precursor 
stages, the adenoma-carcinoma sequence.  In 1990, Fearon and Vogelstein proposed a 
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genetic model for colorectal neoplasia (Figure 1.1) (3).  They described a series of genetic 
alterations and postulated how these alterations affected the process of carcinogenesis, 
starting with the normal epithelium and ending with metastasis.  While they proposed this 
model as the most common order of mutations and tumor development, they noted that it 
may be the accumulation of changes, and not the order, that is important (3).     
Adenomas, the precursor lesions to the majority of colon cancers, are common.    
Studies done postmortem have found that by age 70, approximately 25-50% of people have 
at least one colorectal adenoma.  About 50% of the people who had an adenoma detected 
will have a recurrent adenoma in less than 8 years (4).  The development of an adenoma is 
thought to arise after a mutation in the APC gene, a tumor suppressor gene found on 
chromosome 5q, which allows for disorderly cell replication, adhesion, and migration (5, 6).  
This leads to an accumulation of cells creating a small growth that eventually protrudes from 
the mucosa and is recognizable grossly as a polyp (6).   
In order for the adenoma to progress into cancer, there are several additional steps 
that must occur.  Typically, the DNA of the cells must acquire about half a dozen mutations 
before the tumor becomes cancerous (3, 7).  Some of the most significant of these mutations 
are the activation of oncogenes, like ras, and the inactivation of tumor suppressor genes, like 
p53 (3, 7, 8).  When oncogenes become activated uncontrolled cell growth and replication 
occur (7).  ras gene mutations have been found in approximately 50% of colorectal 
carcinomas and adenomas larger than 1 cm.  This same mutation is present in less than 10% 
of adenomas less than 1 cm in size (3).  Tumor suppressor genes have multiple functions 
including activating DNA repair genes, controlling cellular adhesion, and regulating the cell 
cycle.   In other words, the purpose of the tumor suppressor genes is to slow cell growth, but 
 4 
  
since these genes lose their function, they cannot stop replication of the tumor cells (7).  
When p53 is working properly, it stops tumor growth; however, it has been found that 
tumors have a selective growth advantage even when a wild-type p53 allele is present if the 
there is a point mutation present in the other p53 allele.  Moreover, loss of this wild-type 
allele is often associated with the progression from adenoma to cancer (3).   
 
C. SYMPTOMS  
 In its early stages colorectal cancer causes no symptoms, which is why screening for 
this cancer is imperative.  Once disease progresses, the symptoms will vary depending on 
the size and location of the tumor.  At later stages, common symptoms include: changes in 
bowel habits, blood in the stool, persistent abdominal discomfort/pain, weight loss, fatigue, 
and anemia (9, 10). 
 
D. RISK FACTORS FOR COLON AND RECTAL CANCER  
 
 Although the majority of studies combine cancers of the colon and rectum, these 
may be two distinct cancers with different sets of risk factors.  For example, a recent 
publication by researchers working on the European Prospective Investigation Into Cancer 
and Nutrition study (EPIC) found that waist circumference and waist-hip ratio were 
associated with the risk of colon cancer but were not associated with the risk of rectal cancer  
(11).  Similarly, researchers of the EPIC study also reported that increased physical activity 
decreased the risk of colon cancer but had no effect on the risk of rectal cancer (12).  The 
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same trend was reported in a review of physical activity and cancers of the colon and rectum 
(13).  More research differentiating the risk factors for colon and rectal cancer needs to be 
done.   
 When searching for risk factors for both colon and rectal cancer combined, much 
research has been done examining environmental factors.  One reason for this is that studies 
have reported that the rate of disease in individuals who migrate becomes similar to those of 
their adopted country with increasing duration of residence (14, 15), implying that there is 
something about the environment of their adopted country that increases their risk of 
developing disease.  Diet is a key part of an individual’s environment and has been widely 
studied in the examination of risk factors for colon and rectal cancer.  In addition to the 
information from migrant studies, examining diet as a risk factor also makes sense, as what 
we eat affects what is in contact with the mucosal lining of the colon and rectum.  Studies of 
fruits and vegetables consumption have produced inconsistent results in terms of the 
association with colorectal cancer (5, 10).  Alcohol consumption was shown to increase the 
risk of colorectal cancer but this may be due to its intermediary role in reducing the 
concentration of folate, as folate has been found to decrease the risk of colorectal cancer in 
some studies (5, 10).  Increased calcium intake is believed to decrease the risk of colorectal 
cancer (10).  Red meat consumption is often thought to be associated with an increased risk 
of colorectal cancer though it is unclear whether this is due to the consumption of the meat 
itself or the intake of molecules associated with certain methods employed in cooking the 
meat (5, 10).   
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1.2.2 FATTY ACIDS 
 
A. BIOLOGY OF FATTY ACID DIGESTION 
 Fatty acids include unsaturated fatty acids (which can be in either a cis- or trans- 
formation) and saturated fatty acids.  While lipases from the tongue begin the digestion 
process, most digestion and absorption of fat occurs in the small intestine (7, 16).  In the 
small intestine, pancreatic lipases and bile acids (steroid acids produced in the liver and 
excreted by the gall bladder) begin breaking fatty acids into triglycerides (7, 16).  These 
triglycerides are combined with cholesterol, phospholipids, and other molecules.  They are 
then absorbed from the small intestine and enter into the blood stream (7, 16). 
 Most of the bile acids used to break down the fatty acids are recycled.  They are re-
absorbed in the distal small bowel and travel back to the liver in the portal circulation.  It is 
estimated that between one and five percent of bile acids are unabsorbed and enter the colon 
(16).  The colon works to absorb salt and water remaining from the digested food (7, 16, 17).  
Bacteria present in the colon transform the bile acids into secondary and tertiary bile acids 
that are mostly excreted in the feces (18-21).   
 
 
B. EPIDEMIOLOGIC STUDIES OF FATTY ACIDS AND COLORECTAL CANCER 
It was thought for some time that dietary fatty acids might increase the risk of 
colorectal cancer. However, many published studies have shown that there is no clear 
association between colorectal cancer and dietary fatty acid consumption.  In 1997, Howe et 
al combined the data from thirteen case-control studies of colorectal cancer.  They found no 
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increase in risk of colorectal cancer with increased consumption of total fat intake (22).  
Another review published in 2002, looked at the case-control studies utilized in Howe et 
al.’s study as well as another large case-control study that had been published since then.  
There was again no association between total fat intake and colorectal cancer.  In addition, 
five prospective cohorts examining this association were identified.  Only one out of the five 
studies reported an increase in the risk of colorectal cancer with the increased consumption 
of total fat.  Yet, this increase was attributed to consumption of animal fat (23).  Other 
studies and reviews also confirmed that there was no association between total dietary fat 
consumption and the risk of colorectal cancer (18, 19, 24-27).  
 
1.2.3 TRANS FATTY ACIDS 
 
A. A SPECIFIC FATTY ACID VERSUS TOTAL FAT INTAKE 
 While fatty acids are not associated with colorectal cancer, it is still possible that a 
specific type of fatty acid plays a role in increasing the risk of colon and/or rectal adenomas 
and/or cancer (24).   In one study mentioned above, although the researchers found no 
increased risk of colon cancer with high consumption of overall dietary fat, they did find 
that women at least 67 years of age had an increased risk in colon cancer if they were in the 
two highest quintiles for consumption of fat used in food preparation (i.e. the amount of fat 
used to prepare foods that they ate).  This measure of fat from the food preparation may be 
acting as a proxy for trans fatty acid because fats used in frying foods are often high in trans 
fatty acids (27).  
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B. PRODUCTION OF TRANS FATTY ACIDS 
Trans fatty acids occur naturally in small quantities of some foods. The majority of 
trans fatty acids are the result of partial hydrogenation (28).  This process began in the early 
1900s.  The commonly occurring form of unsaturated fatty acids is the cis- structure (Figure 
1.2).  Hydrogenation uses heat and a catalyst to convert the cis fatty acid into a trans fatty 
acid (29).  This process converts liquids to solids at room temperature.  The fatty acid goes 
from a kinked shape to a more linear one, similar to that of a saturated fatty acid (30).  The 
goal of hydrogenation is to make storage and transportation of oils easier and to increase the 
shelf-life of foods (28, 29, 31).  Trans fatty acids are commonly found in shortenings and 
margarines.  They are present in cookies, crackers, fried foods, baked goods, and other 
processed foods (32).     
 During the past few decades, research has emerged with findings that trans fatty acid 
consumption may be detrimental to one’s health.  Studies show that consumption of trans 
fatty acids increases the risk of coronary heart disease (33).  It may also increase the risk of 
type 2 diabetes (34) and has been shown to increase inflammation in women (35).    
 In response to the public health problem, the Danish government ruled that no oils or 
fats with greater than 2% industrial produced trans fatty acids were allowed to be sold after 
January 1, 2004 (31).  In the United States, activist groups have also taken up the campaign 
against trans fatty acid by suing companies such as Kraft and McDonalds (36).  Labeling of 
trans fatty acid content on food items became mandatory as of January 1, 2006 in the United 
States (37).  Yet, this labeling effort may not have had the desired effect on consumers.  A 
study found that the labeling did not affect consumers’ views on trans fatty acid 
consumption and disease risk.  They state that consumer education is just as important as the 
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labeling (36).  Additional action has been taken in certain localities, such as New York City, 
where trans fatty acids have been banned from use in commercial food outlets (38, 39). 
 
 
C. POSSIBLE BIOLOGIC MECAHNISMS   
 There are several plausible mechanisms by which trans fatty acids could affect 
colorectal carcinogenesis: 
 
1) Fat Absorption, Inflammation, and Oxidative Stress   
A study done in male rats found that the fat excretion:intake ratio was two times 
higher for rats given trans fatty acids than rats fed only cis fatty acids (40).  Studies 
performed in rats have also reported that the type of dietary fat consumed influenced fecal 
diacylglyercol composition (41) and colonic phospholipid composition (42).   
Therefore, it is plausible that the consumption of trans fatty acids results in a 
different concentration and amount of fatty acids than are normally present in the colon.  
This may cause irritation of the colon and rectum, which results in inflammation and 
oxidative stress (43).  Oxidative stress produces free radicals which can damage DNA and 
result in mutations like those seen in the adenoma-carcinoma sequence.  A higher amount of 
an oxidative stress marker (urinary 8-iso-PGF(2alpha)) was found in people who consumed 
trans fatty acids when compared to those without trans fatty acids in their diet (44).  In 
addition, the Nurses Health Study showed that trans fatty acids were associated with 
systemic inflammation (35).  There is some evidence that systemic inflammation, as 
measured by circulating cytokines, is associated with colorectal cancer (45-47), although the 
literature is inconsistent.       
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2) Insulin Resistance 
 In a study of trans fatty acid and insulin sensitivity, rats fed trans fatty acid had 
decreased insulin sensitivity in their adipocytes.  In fact,  trans fatty acids had a greater 
effect than saturated fatty acids on insulin resistance (48).  Little research has been done in 
humans and inconsistencies are present (34).  A few studies found that trans fatty acid 
consumption did not affect insulin resistance in healthy subjects, but insulin resistance was 
affected by intake of trans fatty acid in people with diabetes or insulin resistance (49).   
Two studies looking at metabolic syndrome, which includes dyslipidemia, glucose 
intolerance, insulin resistance, obesity, and hypertension, found that having metabolic 
syndrome increased the risk of colorectal mortality in men (50).  A review of the potential 
mechanisms for the development of colorectal cancer suggests that increased insulin 
stimulates cell signaling pathways to increase proliferation, which will favor cells that are 
defective (such as those with activated oncogenes) (51, 52).   
 In sum, trans fatty acid may increase the risk of colorectal neoplasia by increasing 
insulin resistance, which can lead to heightened cell proliferation.  When oncogenes are 
activated, cell growth is already upregulated and increased cellular proliferation can further 
stimulate these mutated cells to replicate resulting in a cancerous growth.   
 
3) Bile Acids, Inflammation, and Oxidative Stress 
It is also possible that consumption of trans fatty acids leads to an alteration of the 
composition of bile acids different from what is normally found in the colon.  Secondary and 
tertiary bile acids are known to irritate to the colonic mucosa (18, 19).  In addition, some 
studies have shown that bile acids in the colon are metabolized by bacteria (21, 53), 
 11 
  
producing carcinogenic compounds and increasing cellular proliferation.  As stated above, 
colonic irritation and cellular proliferation may increase the risk of colorectal neoplasia. 
 
 
D. EPIDEMIOLOGIC STUDIES 
 An ecologic study performed in Europe found a positive correlation between trans 
fatty acid and colon cancer.  Unfortunately, because this was an ecologic study, the 
researchers could not rule out the possibility that trans fatty acid was simply acting as a 
proxy for another factor (54).   
 After a recent review of the literature, six studies were identified that examined the 
association between trans fatty acid intake and colorectal cancer or adenomas.  These are 
listed in Table 1.1.   
 Only one study looked solely at colon cancer (28).  The researchers divided trans 
fatty acid consumption into quintiles based on the levels of intake in men and women 
controls.  They reported no increase in relative risk for colon cancer in men.  There was an 
increase in the relative risk of colon cancer for women following high consumption of trans 
fatty acid.  In addition, the findings were stronger in people at least 67 years of age.  As well 
as examining the risk of colon cancer by sex, the researchers stratified by use of non-
steroidal anti-inflammatory drugs (NSAIDs) and by estrogen positivity (which they defined 
as being either pre-menopausal or on some sort of hormone replacement therapy).  They 
found no association between trans fatty acid consumption and colon cancer for individuals 
taking NSAIDs.  Among participants who were not taking NSAIDs, there was a positive 
association between colon cancer and trans fatty acid consumption.  Postmenopausal 
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women who did not take any hormone replacement therapy drugs and were in the highest 
quartile of trans fatty acid consumption had the greatest relative risk among other estrogen 
negative and all estrogen positive women (28). 
 Three studies looked at the association between trans fatty acids and colorectal 
cancer (25, 55, 56).  One case-control study demonstrated a positive association between 
trans fatty acid consumption and colorectal cancer among women, but no association was 
detected for men (56).  Neither of the other two studies found compelling evidence to show 
that trans fatty acid intake was associated with colorectal cancer (25, 55).  
 The two studies done to examine the relationship of trans fatty acids and colorectal 
adenomas were performed by McKelvey et al.  Though in both papers the researchers found 
a slight association between colorectal adenomas and high consumption of sweetened baked 
goods, they concluded that overall there was no association between colorectal adenomas 
and consumption of trans fatty acid (29, 57).  Only one of these studies (29) went further to 
investigate the gram amounts of trans fatty acid consumed, but no association was seen.   
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1.3 LIMITATIONS OF STUDIES CURRENTLY IN THE LITERATURE 
 
 While these studies are starting points in the research of the association between 
trans fatty acid and colorectal cancer, there are several points that need to be clarified in 
future research. 
 First, in the studies of colorectal adenomas, trans fatty acid intake is categorized 
based on consumption of foods in specific categories.  Only one of the studies went further 
to examine the overall amount of trans fatty acid consumed.  In that study, because cases 
and controls were classified based on sigmoidoscopy results, it is possible that cases with 
adenomas in the proximal colon were misclassified as controls.  In addition, if trans fatty 
acids differentially affect the proximal and distal sections of the colon, then results of the 
studies based on sigmoidoscopy will differ from those investigating adenomas of the entire 
colon.   
 Another issue is the control of confounding factors.  All six of these studies 
controlled for potential confounding factors such as age and body mass index (BMI) but 
control of other potential confounders was more variable (Table 1.1).  Also, one study found 
effect measure modification by sex, use of NSAIDs, and by hormonal status in women (28).  
While some of the other studies examined if the association between colorectal 
cancer/adenomas and trans fatty acid varied by sex, others did not.  None of the other five 
studies examined NSAID use as a possible effect measure modifier or confounder.   
 In the United States, there is a disparity in the rates of colorectal cancer between 
Whites and African Americans.  If trans fatty acids affect the risk of colorectal cancer and 
there is differential consumption between Whites and African Americans, part of the 
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disparity in colorectal cancer rates may be explained. However, none of the studies have 
included a large population of African Americans about which consumption and risk can be 
compared with that of Whites.   
Finally, as mentioned above, there have been differential effects of risk factors on the 
occurrence colon and rectal cancers.  It may be that trans fatty acids affect the colonic 
mucosa differently than they affect the rectal mucosa.  If this is the case, then risk needs to 
be examined separately for colon and rectal cancers.  Only one study examined the risk of 
colon cancer alone.  No studies have been done to look at the risk of rectal cancer and trans 
fatty acid consumption. 
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1.4 FIGURES AND TABLES 
 
FIGURE 1.1.  Fearon and Vogelstein’s proposed model for colorectal carcinogenesis (3) 
 
 
 
 
FIGURE 1.2. Chemical bonds structures for fatty acids  
 
Saturated Fatty Acid 
 
Unsaturated Fatty Acid 
(cis formation) 
Unsaturated Fatty Acid 
(trans formation) 
H   H 
|     | 
…C--C… 
|     | 
H   H 
H    H 
|      | 
…C==C… 
 
                  H 
                   | 
…C==C… 
        | 
        H 
 
 
5q 
MUTATION OR LOSS 
FAP 
12p 
MUTATION 
K-RAS 
18q 
LOSS 
DCC? 
17p 
LOSS 
P53 
DNA 
HYPOMETHYLATION OTHER 
ALTERATIONS 
NORMAL  
EPITHELIU
M 
HYPERPROLIFERATIVE 
EPITHELIUM 
EARLY 
ADENOMA 
INTERMEDIATE 
ADENOMA 
LATE 
ADENOMA 
CARCINOMA METASTASIS 
CHROMOSOME 
ALTERATION 
GENE 
 16 
 
TABLE 1.1.  Literature review of trans fatty acid consumption and colon/colorectal cancer and adenoma 
Author 
(Year) 
Study 
Design 
Study 
Population Exclusions Exposure Outcome 
Adjusted 
Covariates OR (95%CI) Comments 
COLON CANCER 
Slattery 
(2001) 
Case-
control 
African-
Americans, 
Whites, or 
Hispanics 
from Kaiser 
Permanente 
Medical Care 
Programs (CA, 
UT, MN),  
aged 30-79, 
mentally 
competent to 
complete the 
interview 
 
N=4403 
● Rectal cancer 
● Familial  
   adenomatous  
   polyposis 
● Ulcerative  
    colitis 
● Chron's  
    Disease 
Total trans 
fatty acid 
categorized 
into 
quintiles for 
men and 
women 
controls 
First 
primary 
diagnosis of 
colon cancer 
● Age  
● BMI  
● Physical  
      activity  
● Energy 
● Dietary fiber 
● Calcium intake 
● Estrogen status 
(women only) 
Men:  
1.00 
1.3(1.0,1.8) 
1.3(0.9,1.5) 
1.1(0.9,1.5) 
1.2(0.9,1.7)       
 p-trend: 0.34        
 
Women:  
1.00 
1.0(0.7,1.3) 
1.1(0.8,1.5) 
1.2(0.9,1.6) 
1.5(1.1,2.0)          
p-trend: 0.04 
Also looked 
at OR and 
trend for cis 
fatty acids                                                                         
 
Conducted a 
separate 
analysis for 
interaction 
with NSAIDs 
and HRT 
COLORECTAL CANCER 
Nkondjock 
(2003) 
Case-
control 
French-
Canadians 
living in a 
specific 
region, aged 
35-79 (cases 
were identified 
from five 
major teaching 
hospitals in the 
area; controls 
were identified 
by random 
digit dialing) 
 
N=1070 
●No other  
   primary  
   cancer 
2-year 
period 
before the 
disease: 
calorie-
adjusted 
fatty acid 
was divided 
into 
quartiles for 
men and 
women 
controls 
Histological 
diagnosis of 
colorectal 
cancer 
● Age  
● Total energy  
      intake 
● BMI 1 yr prior  
      to diagnosis 
● History of  
     colorectal  
     cancer in first  
     degree  
     relatives 
● Marital status  
● Physical  
      activity since  
      adulthood 
Men: 
1.00 
1.49(0.88,2.55) 
0.66(0.36,1.21) 
0.88(0.50,1.56)      
p-trend: 0.336        
 
Women: 
1.00 
0.68(0.40,1.35) 
0.81(0.49,1.35) 
1.00(0.61,1.65)       
p-trend: 0.767 
Found sex-
specific 
differences in 
colorectal 
cancer risk 
(most 
associations 
found only in 
women) 
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Lin 
(2004) 
RCT Women's 
Health Study: 
women health 
professionals 
assigned to 
treatment of 
either low-
dose aspirin or 
Vitamin E; 
age>=45 
 
N=37,547 
● History of  
   heart disease   
   and/or  
   cancer 
Categorized 
into 
quintiles 
based on 
overall 
distribution 
of nutrient 
intakes in 
ALL women 
Self-report 
diagnosis of 
colorectal 
cancer 
(verified by 
medical 
files) 
● Age  
● Treatment 
●  BMI 
● Family history  
     of colorectal  
     cancer 
●  History of  
      colorectal  
      polyps 
● Physical  
     activity 
● Smoking 
● Alcohol  
● HRT 
● Total energy  
     intake 
1.00    
0.92(0.59,1.44)     
1.08(0.72, 1.69)   
0.86(0.55,1.40)    
1.30(0.89,2.05)       
p-trend=0.18 
When 
adjusting for 
cholesterol 
and other 
types of fat, 
RR of highest 
quintile 
became 
1.59(0.94,2.7
0) and p-
trend was 
0.06;       
 
Trans fatty 
acid 
consumption 
was not 
associated 
with a 
specific side 
of the colon 
(i.e. proximal 
or distal 
colon cancer) 
Theodoratou 
(2007) 
Case-
control 
Residents of 
Scotland aged 
16-79 (cases 
were recruited 
from patients 
at surgical 
units in 
Scottish 
Hospitals with 
adenocarcinmoas; 
controls were 
identified from 
a population-
based register) 
● Death prior  
   to  
  ascertainment  
● Too ill to  
    participate 
●Not able to  
   provide  
   informed  
   consent 
● Previous  
   diagnosis of   
   colorectal  
   cancer 
Diet during 
the 1-year 
period 
before the 
disease: 
energy-
adjusted 
fatty acid 
was divided 
into quartiles 
based on the 
distribution 
in cases and 
controls 
First 
diagnosis of 
colorectal 
cancer 
● Age 
● Sex 
● Area of  
   residence 
● Total energy  
     intake 
● Family history  
   of colorectal  
   cancer 
● Total fiber  
     intake 
● Total alcohol  
     intake 
● NSAID use 
Overall:  
1.00 
1.28(1.01,1.63) 
1.18(0.93,1.50) 
1.05(0.82,1.35)      
p-trend: 0.856        
 
Men: 
1.00 
1.14(0.84,1.55) 
0.99(0.73,1.35) 
0.95(0.69,1.32)      
p-trend: 0.572        
 
Also looked 
at trans 
mono-fatty 
acids (results 
were 
approximatel
y the same as 
those for total 
trans fatty 
acids) 
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N=2910 
● Smoking status 
● BMI 
● Physical  
   activity 
Women: 
1.00 
1.53(1.04,2.25) 
1.58(1.06,2.35) 
1.28(0.85,1.91)       
p-trend: 0.230 
 
 
COLORECTAL POLYP 
McKelvey 
(1999) 
cross-
sectional 
English-
speaking 
people aged 
50-74 living in 
Los Angeles 
area 
 
N=1072 
●Prior polyps,  
   history of      
   bowel  
   surgery,  
   IBD, cancer,  
   familial  
   polyposis 
Foods were 
grouped 
based on 
ingredients 
since 
amounts of 
trans fatty 
acids could 
not be 
identified.  
These 
groups were: 
sweetened 
baked 
goods; 
candy bars; 
oils and 
condiments; 
and french 
fries and 
chips;         
Also, used 
this info and 
number of 
servings to 
estimate a 
person's 
trans fatty 
acid intake 
Histological 
diagnosis of 
colorectal 
adenomatous 
polyp 
through 
sigmoidoscopy 
● Age 
● Sex 
● Smoking 
● BMI 
● Physical  
      activity 
● Total energy 
● Red meat 
●Vegetables 
● (Sweetened  
       baked goods  
       - in some  
       analyses) 
Overall trans fatty 
acid intake:           
< 2 grams   
1.00           
 2 to <4 grams  
1.0(0.71,1.4)     
4 to <6 grams      
1.5(0.91-2.5)     
6+ grams   
1.6(0.82,3.2) 
 
Sweetened baked 
goods:         
0-50 calories  
1.0 
50-100 calories 
1.3(0.83-1.9)      
…300-350 calories 
1.9(0.89,3.9)   
350+ calories 
2.1 (1.3,3.5) 
Positive 
association 
between 
sweetened 
baked 
goods and 
adenomas; 
also 
positive 
assoc 
between 
total trans 
fatty acid 
consumptio
n and 
adenomas 
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McKelvey 
(2000) 
cross-
sectional 
People 
referred to 
UNC 
Hospitals for 
colonoscopy, 
aged 30-89 
 
N=641 
●History of  
   polyposis,  
   colitis,  
   previous  
   bowel  
   surgery,  
   previous  
   adenoma,  
   previous  
   colon cancer,  
  unsatisfactory  
   prep,  
   incomplete  
   exam 
Same as 
above (also, 
calculated 
PHVO in 
frying 
process by 
subtracting 
amount of 
fat in broiled 
chicken or 
fish from the 
amount of 
fat in fried 
chicken or 
fish) 
Diagnosis of 
at least one 
adenomatous 
polyp 
● Age 
● Sex 
● Smoking 
● Weight 
● Height 
● Physical  
      activity 
● Total energy 
● Red meat 
● Vegetables 
● Alcohol 
● Family history 
Sweetened baked 
goods:         
0-100 calories  
1.0                
100-200 calories 
1.2(0.70-1.9)                 
200-300 calories 
2.3(1.2,4.6)   
300-400 calories 
1.3(0.73,2.9)   
400+ calories            
1.9 (0.95,3.8)  
 
Oils and 
condiments:         
0-100 calories  
1.0                
100-200 calories 
1.2(0.77-1.8)                 
200+  calories    
2.4 (1.3,4.2) 
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2. SPECIFIC AIMS AND STUDY HYPOTHESES 
 Dietary factors play a large role in the risk of colorectal cancer.  Although no 
association has been found between colorectal cancer and total dietary fat, trans fatty acid, a 
particular type of dietary fat, may increase the risk of colorectal cancer.  If trans fatty acid 
consumption is a risk factor for colon cancer, rectal cancer, or colorectal adenomas, it would 
be important to know this for a few reasons.  First, advocacy groups working to have trans 
fatty acids removed from foods could utilize this information.  Second, consumers could use 
this information to make educated choices about what they want to eat. 
Thus far, very few studies have looked at the risk of colorectal cancer/adenomas and 
consumption of trans fatty acids and most of these studies had limitations. The research 
performed in this dissertation addressed and accounted for the limitations present in the 
other studies.  It also examined the association for both location of the tumor (colon versus 
distal colon/rectum) and stage in the carcinogenesis process (adenoma versus cancer).  In 
addition, no prior studies had investigated the consumption patterns and their influence on 
risk of colon and distal colorectal cancer in a study population with a large number of 
African Americans.   
 I hypothesized that increasing consumption of trans fatty acids would increase the 
risk of colon/rectal cancer/adenomas.  This study had three specific aims: 
1)  To determine whether increasing consumption of trans fatty acid is 
associated with increased prevalence of colorectal adenomas (defined as
26   
 
      adenomas present throughout the entire colon and rectum).  To 
accomplish this aim, I utilized the Diet and Health Study IV dataset 
(results summarized in Chapter 4) 
2) To determine whether increasing consumption of trans fatty acid is 
associated with colon cancer (defined as cancer present from the cecum 
through sigmoid colon).  To accomplish this aim, I utilized the North 
Carolina Colon Cancer Study I dataset(results summarized in Chapter 5). 
3) To determine whether increasing consumption of trans fatty acid is 
associated with distal colorectal cancer (defined as cancers of the sigmoid 
colon, rectosigmoid, or rectum).  To accomplish this aim, I utilized the 
North Carolina Colon Cancer Study II dataset (results summarized in 
Chapter 6). 
 
 
 
 
 
 
 
 
 
 3. RESEARCH DESIGN AND METHODS 
 
 
3.1 OVERVIEW 
   
 In order to investigate the above hypotheses, I used the data from three studies.  The 
first aim, examining the relationship between colorectal adenomas and trans fatty acid 
consumption, utilized the data from the Diet and Health Study IV (DHS IV).The second 
aim, examining the association between colon cancer and trans fatty acid intake, was 
assessed using the North Carolina Colon Cancer Study I (NCCCS I).  Finally, the third aim, 
looking at the relationship between distal colorectal cancer and trans fatty acid consumption, 
was investigated using the North Carolina Colon Cancer Study II (NCCCS II).  The study 
population, data collection, and variable measurement for each of these are described in 
more detail in the following sections.  The analysis of this previously collected data met the 
guidelines for exclusion from IRB approval (See Appendix). 
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3.2 STUDY POPULATION 
 
 
Diet and Health Study IV (DHS IV) 
DHS IV recruited consecutive patients undergoing an outpatient colonoscopy at the 
University of North Carolina Hospitals in Chapel Hill, North Carolina from November 2001 
to December 2002.  In this study, cases were defined as people who had a colorectal 
adenoma detected during complete colonoscopy.  Eligibility requirements were as follows: 
aged 30-80 years old, ability to give informed consent, a satisfactory prep for colonoscopy 
and a complete exam, no previous colonoscopies, not an inpatient, and no history of familial 
polyposis, colitis, previous colonic resection, or previous colon cancer or polyps.  Controls 
were defined as those patients that had a colonoscopy during this time period but had no 
adenomas present.   
 
North Carolina Colon Cancer Study (NCCCS) 
 NCCCS I was a population-based case-control study taking place in central North 
Carolina.  It enrolled subjects from 33 counties, representing urban, suburban, and rural 
areas of the state.   
 Cases were identified using the rapid case ascertainment system of the North 
Carolina Central Cancer Registry.  Those patients with a first diagnosis of histologically 
confirmed invasive adenocarcinoma between October 1996 and September 2000 were 
classified as potential cases.  Additional eligibility requirements were as follows: aged 40-80 
years, residence in one of the 33 counties, able to give informed consent, able to complete an 
interview, had a North Carolina driver’s license or identification card issued by the North 
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Carolina Department of Motor Vehicles (if under the age of 65) , and had no objections from 
the primary physician in regards to contacting the individual.  White cases were under-
sampled in order to increase the proportion of non-White cases in the study population.   
 Controls were selected from two sources.  For those under the age of 65, potential 
controls were identified using the North Carolina Department of Motor Vehicles records.  
For those 65 years and older, records from the Center for Medicare and Medicaid Services 
(previously the Health Care Financing Administration) were used to ascertain a control 
group.  Potential controls were contacted in a manner similar to that of the cases.  Controls 
were matched to cases using randomized recruitment strategies (1).  This method of 
matching works well for many reasons, including the concurrent recruitment of cases and 
controls into the study (1).  In the NCCCS I, recruitment probabilities, and therefore 
probability matching, were done using strata of 5-year age, sex, and race groups. 
 
North Carolina Rectal Cancer Study II (NCCCS II) 
 NCCCS II was a study almost identical to the NCCCS I except that the cases 
included only patients with cancer of the sigmoid colon, rectosigmoid, and rectum.  Cases 
and controls in this study were recruited between November 2001 and August 2006.   
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3.3 DATA COLLECTION 
 
Diet and Health Study IV (DHS IV) 
Within twelve weeks of their colonoscopy, patients who consented to the study were 
followed up with by a phone call from a trained interviewer.  The interviewer was blinded as 
to whether the participant was a case or a control.  Information on diet, physical activity, 
demographics, and other such factors were obtained at this time (see Section 3.6 for more 
details on the measurement of physical activity).  Height and weight were measured at the 
time of colonoscopy.  No incentive was given other than to supply individuals with the 
results of their personal dietary assessment.   
 During the study period, there were 3182 colonoscopies performed at the UNC 
Hospitals.  The majority of these individuals (2155) were deemed ineligible and not 
recruited for the study.  Of the remaining 1027 individuals, 91 individuals were not asked to 
participate because the research assistant was not available and 123 individuals did not 
consent to participation in the study.  One hundred seven individuals were classified as 
ineligible after the procedure was completed.   The study was completed by 701 individuals 
(196 cases and 505 controls).  The response rate for completion of the study was 76% 
(interview/eligible).   
 
North Carolina Colon Cancer Studies I and II (NCCCSs I and II) 
 Potential participants received a call from a race-matched enrollment specialist who 
explained the study.  After consent for participation was obtained, an in-person interview 
was scheduled.  Trained nurse interviewers collected data at the individual’s house or 
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another convenient location. The interviews took place within approximately five months of 
a case’s diagnosis.  Participants were asked questions pertaining to demographic 
information, lifestyle factors, diet, and medical history.  Information on physical activity, 
height, and weight was also collected (see section 3.6 for more detail on the measurement of 
physical activity and BMI).  Both cases and controls were offered a $25 incentive for 
participation in the study.  
 NCCCS I 
 Among those who were eligible, reasons for not being interviewed were as follows: 
refusal (14% cases; 36% controls), untraceable (1% cases, 1% controls), not reachable by 
phone (6% cases, 1% controls), and physician denial (7% cases).  Completed interviews 
were obtained for 1691 people (643 cases, 1048 controls).  The rate of study cooperation 
(interviewed/(interviewed+refused)) was 84% for cases and 63% for controls. The response 
rates (interview/eligible) for cases and controls were 72% and 61% respectively.   
NCCCS II 
 Among those who were eligible to participate in the study, the following reasons 
were given for why no interview was done: refusal (17% cases; 26% controls) and 
untraceable/not reached (8% cases, 18% controls).  A total of 3106 people completed 
interviews (1045 cases and 1019 controls), giving study cooperation rates 
(interviewed/(interviewed+refused)) as 81% and 68% and  response rates 
(interview/eligible) of 74% and 56% for cases and controls, respectively.    
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3.4 MEASUREMENT OF EXPOSURE 
 
Diet and Health Study IV(DHS IV) and North Carolina Colon Cancer Study II (NCCCS II) 
 The DHS IV and the NCCCS II used the Diet History Questionnaire (DHQ), 
a validated food frequency questionnaire developed by the National Cancer Institute (NCI) 
(2, 3).  The DHQ contained 124 food items and was not modified in any way.  The time 
period referenced in the study was one year prior (DHS IV: one year prior to the interview 
date; NCCCS II: one year prior to diagnosis for cases and one year prior to the interview 
date for controls), which allowed us to capture seasonal variations in diet.  People were 
asked to report both their typical portion size and frequency of consumption, which varied in 
range for each food item.   This questionnaire also asked questions about how foods were 
generally cooked and what sorts of fats were used in the cooking process.   
 The corresponding diet calculator (Diet*Calc) was downloaded from the NCI’s 
website.  This program was run for all study participants to determine their total intake of 
various nutrients and components of diet.   
 
North Carolina Colon Cancer Study I (NCCCS I) 
 In this study, diet was collected using a modified version of the 100-item 
semiquantitiative Block Food Frequency Questionnaire (FFQ) (4).  The modification that 
took place was the addition of twenty-nine foods commonly consumed in North Carolina, 
such as hush puppies and greens.   
 Each food item had three choices for portion size (given as “small,” “medium,” and 
“large”) and nine choices for frequency (ranging from “never or less than once per month” 
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to “2+ times per day”).  When estimating frequency and portion size, study participants were 
asked to use the reference period of one year (one year prior to diagnosis for cases and one 
year prior to the interview date for controls).  Participants were asked to estimate their usual 
consumption over the period of a year in order to capture the seasonal variation present in 
consumption of some foods.  Additional questions were asked about the following: types of 
foods used in cooking and preparation techniques, fortified beverages consumed, low-fat 
foods consumed, and restaurant eating. 
 Unfortunately, determining the amounts of trans fatty acids present in an 
individual’s diet was much more difficult for this study.  There were no values for trans 
fatty acids in the nutrient database associated with the Block FFQ.  With the help of the 
Clinical Nutrition Research Center at the University of North Carolina, we paired each food 
listed in the Block FFQ with food(s) listed in the NCI’s DHQ.  We assigned the amount of 
trans fatty acid listed for each food in the DHQ to the corresponding food in the Block FFQ 
(per 100 grams of food).  If more than one DHQ food matched, we applied the mean amount 
of trans fatty acids for those foods to the corresponding Block FFQ food.  For example, one 
of the foods in the Block FFQ is “cookies, cake.”  In the DHQ there are three foods that 
matched: “cookies, brownies,” “cakes,” and “cheesecake.”  The amount of trans fatty acids 
assigned to each of these was averaged to determine the amount of trans fatty acids that 
would be assigned to “cookies, cake” in the Block FFQ.  Of the 201 Block FFQ foods, 176 
(87.6%) were matched in this manner to foods in the DHQ.  For the remaining foods, we 
searched for trans fatty acid values in the USDA National Nutrient Database for Standard 
Reference (Release 19).  Eight more foods were given values (4.0%).  We were unable to 
determine the amount of trans fatty acid in 17 foods (8.5%), which were assigned values of 
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0 grams of trans fatty acid.  The majority of these foods (12 foods) were vegetables, fruits, 
or fruit juices so it is unlikely that assigning them a value of 0 will have an affect on the 
results. 
We employed the same methods to derive the energy intake variable.  One hundred 
percent of the Block FFQ foods were matched and assigned caloric values.  This was done 
primarily using the same Block FFQ-DHQ pairings that we used for trans fatty acids.  For 
the remaining foods, we used values from the USDA National Nutrient Database.  The 
original values for caloric intake present in the Block FFQ and the values determined using 
the DHQ and USDA databases were highly correlated (correlation was greater than 0.99).      
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3.5 MEASUREMENT OF OUTCOME 
 
 As described above, cases are those patients identified as having either a colorectal 
adenoma (DHS IV), colon cancer (NCCCS I), or distal colorectal cancer (NCCCS II).  In the 
DHS IV, the study pathologist reviewed every slide.  In addition, a 10% random sample of 
all biopsies collected were resubmitted for review.  This was done to assess the reliability of 
the case-control classification.  Ninety-nine percent of classifications were concordant.  In 
the NCCCSs I and II, all of the diagnoses were confirmed by the study pathologist using 
pathology reports.  In addition, over 95% of the diagnoses were confirmed using the 
pathology slides.   
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3.6 MEASUREMENT OF OTHER KEY VARIABLES  
 
Information on all covariates of interest was collected during the interviews or prior 
to colonoscopy.  For all three studies, physical activity was measured for occupational, non-
occupational, and non-work/weekend activities using a modified version of a validated 
seven-day physical activity recall (5-7).  Frequency, intensity, and duration was estimated 
and converted into a variable giving MET minutes per day.  Body mass index (BMI) was 
calculated using the height and weight of each participant.  Participants of the DHS IV had 
their height and weight measured at the time of their colonoscopy.  Participants of the 
NCCCSs I and II had their height and weight measured at the time of interview.  They also 
reported their weight one year prior in order to capture weight prior to any changes that 
occurred as a result of disease or treatment in the cases.  Dietary variables to be used as 
covariates in the study were obtained from each study’s food frequency questionnaire 
(discussed above).  Information on family history of colorectal cancer, smoking status, and 
NSAID use were gathered during the interview.   
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3.7 DATA ANALYSIS 
 
 The statistical analyses conducted in this study were performed using STATA 
version 8.2 (8).  We excluded participants with extreme values for energy intake as we felt 
that their responses may not be valid.  Men reporting total calories per day less than 800 kcal 
or greater than 5000 kcal were removed from further analysis.  The corresponding values for 
women were 600 and 4000 kcal.  In addition, because we were interested, a priori, in 
stratifying analyses of the NCCCSs I and II by race, we excluded participants of these 
studies who gave a self-report race as “other,” in order to keep only individuals that self-
identified as White or African American in the dataset.   
Trans fatty acid intake was used as a energy-adjusted variable.  Besides potentially 
confounding the association, total energy intake can add variation and weaken the 
association present between trans fatty acid intake and the outcome (9).  As stated by Dr. 
Willett and Dr. Stampfer in their paper on total energy intake:  
…Before attributing causality to a specific nutrient, the burden is upon the 
epidemiologist to demonstrate that the effect of this nutrient is independent of 
caloric intake (10).   
 
They suggest that the best method for doing this is through the employment of residuals 
from a regression model where the independent and dependent variables are total caloric 
intake and nutrient intake, respectively (10).  While the residual method of calorie 
adjustment is most often used for continuous values of nutrient intake, it is also appropriate 
to use when categorizing nutrient intake variables (11).  Therefore, we energy-adjusted the 
variable of trans fatty acid using the residuals method.  The exposure variable, residuals of 
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trans fatty acids consumption, was then converted from a continuous variable to a 
categorical one.  Quartiles were created based on the distribution in the control population.   
 Unconditional logistic regression modeling was used to explore the relationship 
postulated in each of the specific aims.  In order to generate unbiased effect estimates, offset 
terms were included in the models for the NCCCSs I and II to correct for the randomized 
recruitment sampling fractions, as discussed above (1, 12).  Effect measure modification was 
assessed using a test of homogeneity and a likelihood ratio test with a p-value cut-off of 
0.15.  A priori, the variables chosen to be assessed for effect measure modification in the 
DHS IV analysis were sex and NSAID use.  For the NCCCSs I and II these were sex, 
NSAID use, and highest level of education attained. Confounding was assessed for multiple 
variables.  First, a directed acyclic graph depicting the relationship occurring between trans 
fatty acid intake, colon/rectal cancer/adenoma, and the possible confounding factors was 
drawn to get a better understanding of which variables might qualify as confounders (Figure 
3.1).  From this figure and knowledge of what prior studies of the trans fatty acid-colorectal 
cancer relationship have identified as potential confounders, the following variables were 
identified and examined as possible confounding factors: age, sex, race, family history of 
colorectal cancer, BMI, physical activity, NSAID use, smoking status, highest level of 
education achieved, vegetable consumption, red meat consumption, calcium intake, and 
alcohol consumption.  Once working with the actual data, the criteria for confounding 
proposed by Drs Rothman and Greenland were used to identify variables that met the 
definition of a confounder.  Based on this criteria, a confounder must: a) be a risk factor for 
the disease among the unexposed; b) be associated with the exposure in the source 
population from which the study population was drawn; c) be unaffected by the exposure or 
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the disease (i.e. not on the causal pathway) (13).  These variables were then checked to see if 
they met the assumption of linearity.  If the assumption was not met, the variable was dealt 
with by creating indicator variables to use in the final model.  Once the full model was 
determined (a model including the exposure, interaction terms for effect measure modifiers, 
all possible confounding variables, and offset terms, where applicable) backwards 
elimination with a 10 percent change-in-estimate criterion was used to refine the model.   
Additional analyses were conducted in each of the three studies using multinomial 
logistic regression.  In the DHS IV study, adenoma characteristics were analyzed to see if 
any of these was associated more strongly with trans fatty acid consumption.  Location 
(proximal or distal), size (none, less than one centimeter, or one centimeter or greater based 
on the size of the largest adenoma), and number (none, one adenoma, more than one 
adenoma) were studied, with controls serving as the referent outcome for all analyses.  
Location was classified as proximal if an adenoma was detected in the cecum, ascending 
colon, hepatic flexure, or transverse colon and as distal if an adenoma was present in the 
splenic flexure, descending colon, sigmoid colon, or rectum.  Participants with adenomas in 
both the proximal and distal colon were excluded.  In addition to these analyses on the 
prevalence of colorectal adenomas, we investigated the association between trans fatty acid 
consumption and the type of polyps identified during colonoscopy.  Participants with polyps 
were categorized as having either hyperplastic or adenomatous polyps and were categorized 
as controls if they had neither hyperplastic polyps nor adenomatous polyps detected.  If a 
participants had both hyperplastic and adenomatous polyps, they were excluded.  Location 
of the cancer was further investigated in the NCCCSs I and II.  For the NCCCS I, cancer 
was classified as being located in the proximal or distal colon, using the same definition as 
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used for the DHSIV.  For the NCCCS II, cancers were identified as being located in either 
the sigmoid colon, rectosigmoid, or rectum. The associations for specific types of trans fatty 
acids were also evaluated in the NCCCS II.  In each of these additional analyses, 
confounding factors were re-evaluated to be sure that the final model being presented was 
not biased as a result of lack of control for confounders.   
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3.8 FIGURE 
 
FIGURE 3.1. Directed acyclic graph of the relationship between trans fatty acid 
consumption and colon cancer, rectal cancer, and colorectal adenomas* 
 
 
 
 
 
*Even though some risk factors are known to affect colon cancer and not rectal cancer, for simplicity, all of the 
outcomes were combined in this figure. 
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4. RESULTS PAPER 1: Consumption of Trans Fatty Acid and its 
Association with Colorectal Adenomas 
 
4.1 ABSTRACT 
 
Trans fatty acid consumption is known to have detrimental effects on cardiovascular health, 
but little is known about its role in digestive tract neoplasia.  In order to investigate the 
association between colorectal adenomas and trans fatty acid consumption, data from a 
cross-sectional study of 622 individuals who underwent complete colonoscopy between 
2001 and 2002 at the University of North Carolina Hospitals were utilized.  Participants 
were interviewed about demographic, lifestyle, and dietary factors thought to be related to 
colorectal cancer.  Energy intake-adjusted trans fatty acid consumption was categorized into 
quartiles based on its distribution in controls.  Compared to participants in the lowest 
quartile of trans fatty acid consumption, those in the highest quartile had an increased 
prevalence of colorectal adenomas, with an adjusted prevalence odds ratio of 1.86 (95% 
confidence interval: 1.04, 3.33).  We further investigated the relationship between trans fatty 
acid consumption and colorectal neoplasia by examining the adenoma characteristics, with 
the adjusted prevalence odds ratios showing little or no difference by adenoma location, 
size, or number.  These results suggest that consumption of high amounts of trans fatty acid 
may increase the risk of colorectal neoplasia and provide additional support to 
recommendations to limit trans fatty acid consumption.    
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4.2 INTRODUCTION 
 
Colorectal cancer is a major health concern in the United States, with over 150,000 
diagnoses and 52,180 deaths expected in the year 2007 (1).  It is widely accepted that the 
majority of colorectal cancers develop from precursor lesions, colorectal adenomatous 
polyps.  Recent colonoscopy based studies have shown that adenomas are very common.  
Rex et al (2) reported that 66 percent of a study population aged 50 and over had at least one 
adenoma, a higher percentage than most previous reports.  The rate of adenoma detection in 
participants who were undergoing screening colonoscopy for the first time was 55 percent 
(2).   An earlier study also detected adenomas in 55 percent of study participants undergoing 
screening colonoscopies at a Veterans Affairs Hospital.  Patients with adenomas are more 
likely to develop additional adenomas in the future, with a reported recurrence rate of 37 
percent within 5 years (3).  The concern about adenomas stems from the fact that they can 
progress to cancer; therefore preventing adenomas from developing by modifying diet or 
lifestyle could decrease the incidence of colorectal cancer.   
Currently, there is increasing concern that consumption of trans fatty acids may 
contribute to disease risk.  This is especially true for heart disease (4) but higher intakes 
have also been found to be detrimentally associated with other health outcomes, such as type 
II diabetes (5).  Consequently, all nutritional labels in the United States were required to 
include information on trans fat content by January 1, 2006 (6).  In addition, some localities, 
including New York City, have banned trans fatty acids from commercial food outlets (7, 
8). 
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 There is little published information on trans fatty acid consumption and colorectal 
neoplasia, but there are several mechanisms by which trans fatty acids could influence the 
risk of colorectal neoplasia.  For example, trans fatty acid consumption may lead to elevated 
risk of developing colorectal adenomas by altering the concentration of bile normally found 
in the colon, resulting in irritation of the colonic mucosa (9-13), increasing oxidative stress 
(14), or increasing insulin resistance (12, 15-17).    
We used data from a cross-sectional study of subjects attending UNC Hospitals for a 
colonoscopy to investigate the association between colorectal adenomas and trans fatty acid 
consumption.  We also examined the relationship between trans fatty acid consumption and 
the location, number, and size of adenomas.  In contrast to prior publications, the present 
study reports the relationship between energy-adjusted trans fatty acid consumption and 
colorectal adenomas among participants who had their entire colon examined by complete 
colonoscopy.   
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4.3 MATERIALS AND METHODS 
 
4.3.1 STUDY POPULATION 
The Diet and Health Study IV (DHS IV) recruited consecutive patients undergoing 
an outpatient colonoscopy at the University of North Carolina Hospitals in Chapel Hill, 
North Carolina from November 2001 to December 2002.  The study received Human 
Subjects Approval from the School of Medicine IRB and research assistants obtained 
written informed consent from individuals prior to their colonoscopy.  Eligibility 
requirements were as follows: age 30-80 years, proficient in English, ability to give 
informed consent, a satisfactory prep for colonoscopy and a complete exam to the cecum, no 
previous colonoscopies, not an inpatient, and no history of familial polyposis, colitis, 
previous colonic resection, or previous colon cancer or polyps.  For this study, cases were 
defined as subjects who had a colorectal adenoma (a polyp with tubular, villoglandular, or 
villous histology) detected during complete colonoscopy.  Controls were defined as those 
subjects with no adenomas present.  A single study pathologist examined all tissue samples 
collected from participants and reported the diameter, location, and histologic type of each 
polyp detected.  In addition, a 10 percent random sample of all biopsies collected from the 
study participants was blindly resubmitted for pathology review to determine the reliability 
of the case-control classification; 99 percent of classifications were concordant. 
 
4.3.2 DATA COLLECTION 
Within twelve weeks of their colonoscopy, consenting subjects were followed up 
with a phone call from a trained interviewer who was blinded to case-control status.  
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Interviewers collected information on participants’ age, sex, educational background, race, 
smoking history, non-steroidal anti-inflammatory drug (NSAID) use, and physical activity.  
Physical activity was measured for occupational, non-occupational, and non-work/weekend 
activities using a modified version of a validated seven-day physical activity recall (18-20).  
Height and weight were measured at the time of colonoscopy.  
 
4.3.3 DIETARY ASSESSMENT 
 Dietary information was collected during the interview using the validated Diet 
History Questionnaire (DHQ) developed at the National Cancer Institute 
(21-23).  Participants were asked to use a reference period of one year prior to their 
colonoscopy, allowing us to capture usual diet across seasons.  The DHQ included questions 
on portion size and frequency of consumption for each food.  The DHQ also accounted for 
cooking methods individuals employed.  
 
4.3.4 DATA ANALYSIS 
Trans fatty acid consumption, was energy-adjusted using the residuals method from 
a regression model where the independent and dependent variables were energy intake and 
trans fatty acid intake, respectively (24).  This method results in trans fatty acid values that 
are independent of an individual’s overall amount of energy consumed.  While the residual 
method of energy adjustment is most often used for continuous values of nutrient intake, it is 
also appropriate when categorizing nutrient intake (25).  The residuals of trans fatty acid 
consumption were categorized into quartiles based on consumption in the adenoma-free (i.e. 
control) population. 
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 We used logistic regression modeling to explore the associations between colorectal 
adenomas and energy-adjusted trans fatty acid consumption.  Sex and NSAID use were 
assessed as potential prevalence odds ratio modifiers using tests of homogeneity and 
likelihood ratio tests with a p-value cut-off of 0.15.  These two variables were selected 
because a study of colon cancer and trans fatty acid consumption demonstrated differences 
within stratum of similar variables (26) and because NSAIDs have been shown an inverse 
association with adenoma prevalence and recurrence (27-29) and could alter the effects of 
trans fatty acids if they create inflammation.  Adenomas are more common in men, older 
individuals, and African Americans and trans fatty acid consumption was associated with 
age, sex, and race among the controls; therefore we adjusted for these variables a priori.  In 
addition, we evaluated family history of colorectal cancer, body mass index (BMI), physical 
activity, NSAID use, smoking status, alcohol consumption, calcium consumption, red meat 
consumption, and total vegetable serving consumption as potential confounders according to 
a 10 percent change-in-estimate criterion.     
 We also investigated associations between trans fatty acid consumption and 
adenomas classified according to their location (proximal or distal), size (none, less than one 
centimeter, or one centimeter or greater based on the size of the largest adenoma), and 
number (none, one adenoma, more than one adenoma), with controls serving as the referent 
outcome for all analyses.  Location was classified as proximal if an adenoma was detected in 
the cecum, ascending colon, hepatic flexure, or transverse colon and as distal if an adenoma 
was present in the splenic flexure, descending colon, sigmoid colon, or rectum.  If a 
participant had an adenoma in both the proximal and distal colon, they were excluded from 
this analysis (n=30).  We estimated these associations using multinomial logistic regression.   
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 In addition, we investigated the association between trans fatty acid consumption 
and two types of polyps.  For these analyses, participants with polyps were categorized as 
having either hyperplastic or adenomatous polyps.  Participants were categorized as controls 
if they had neither hyperplastic polyps nor adenomatous polyps detected during 
colonoscopy.  Participants with both hyperplastic and adenomatous polyps were excluded 
from this analysis (n=50).  The exposure, consumption of trans fatty acids, retained the same 
categorization despite the change in the control group.  If cut-points had been reformatted 
based on the distribution of consumption in the specific control group used in these analyses, 
99 percent of individuals would have remained in the same exposure category.  Multinomial 
logistic regression was employed and confounding was reassessed using the 10 percent 
change-in-estimate criteria.     
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4.4 RESULTS 
 
 Between November 2001 and December 2002, 1,027 eligible individuals had a 
colonoscopy performed at the UNC Hospitals.  Of these individuals, 91 were not asked to 
participate because the research assistant was not available, and 123 did not provide consent 
for participation in the study.  One hundred seven were classified as ineligible after the 
colonoscopy was completed for reasons such as an unsatisfactory prep or an incomplete 
exam.   The study was completed by 701 individuals, with a response rate (number 
interviewed/number eligible) of 76 percent.  
 Complete information on colorectal adenomas and trans fatty acid consumption was 
available for 622 participants (173 cases and 449 controls).  Characteristics of the study 
participants by case and control status are given in Table 4.1.  Mean age at time of interview 
was similar for the cases and controls (57 and 56 years, respectively).  There were more 
women than men in the study population, but more men had colorectal adenomas detected.  
Over 75 percent of study participants were white and more than half had at least a college 
degree.  As expected, a higher proportion of cases than controls were classified as obese 
(BMI ≥30 kg/m2; 31 versus 24 percent, respectively).  Cases also had a higher mean 
consumption of alcohol and a slightly higher energy intake than controls.   
Cases reported higher unadjusted trans fatty acid consumption than controls, with a 
mean of 4.97grams (SD 3.20 grams) and median of 4.12 grams compared with 4.42 grams 
(SD 3.16 grams) and 3.61grams, respectively, in controls (t-test p of 0.054).  The crude 
(unadjusted) prevalence odds ratio comparing the highest quartile of trans fatty acid 
consumption to the lowest quartile was 1.55 (95% confidence interval (CI): 0.95, 2.54).   
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  Prevalence odds ratios were homogeneous across strata of sex and NSAID use 
(likelihood ratio test p>0.15), therefore multiplicative interaction terms between these 
covariates and the exposure were not retained.  The following variables were entered into 
the final model as confounders: age (continuous), sex, race (categorized as white, non-
white), physical activity (continuous), BMI (continuous), and alcohol consumption 
(continuous).  In addition to adjusting the exposure, trans fatty acid consumption, for energy 
intake, a continuous variable for energy intake was included in the final model.  For the 
multinomial model comparing subjects with hyperplastic polyps and adenomatous polyps to 
controls, smoking status (categorized as never, former, current smoker), consumption of red 
meat (continuous), and total number of vegetable servings consumed (continuous), were also 
found to be confounders based on a 10 percent change in estimate criterion and were added 
to the model in addition to the covariates above.    
The fully adjusted prevalence odds ratio comparing those in the lowest quartile of 
trans fatty acid consumption to those in the highest quartile was 1.86 (95% CI: 1.04, 3.33) in 
the fully adjusted model (Table 4.2).  Consumption of trans fatty acid was not associated 
with the prevalence of colorectal adenomas for those in the second or third quartiles of 
consumption.  Estimates from the minimally adjusted models were similar (Table 4.2).   
 Other categorizations were undertaken to further examine the association present in 
the extreme quartile of trans fatty acid consumption (data not shown).  Although it was 
difficult to draw definitive conclusions regarding a specific threshold of trans fatty acid 
consumption due to small numbers, similar trends were seen.  In models of the various 
categorizations the highest 20-25 percent of energy-adjusted trans fatty acid consumption 
had similar point estimates to those seen in the highest quartile of consumption from our 
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original model.  These results confirm the appearance of a threshold affect; the prevalence of 
adenomas was increased only among those with the highest levels of trans fatty acid 
consumption in our study population.   
 The results of the minimally and fully adjusted models for the investigation of 
adenoma location, size, and number were very similar and therefore only the results of the 
fully adjusted model are presented (Table 4.3).  As seen in the models examining only the 
presence/absence of colorectal adenomas, the fourth quartile of consumption was associated 
with the largest increase in prevalence among all categories of location, number, and size of 
adenomas.  Adenomas in the proximal colon were more strongly associated with high 
consumption of trans fatty acids (POR: 2.80; 95% CI: 1.14, 6.87) than adenomas of the 
distal colon (POR: 1.51; 95% CI: 0.68, 3.35); however, for the fourth quartiles the p-value 
for the difference between the two adenoma locations was 0.28.  Also, there does not appear 
to be a difference in the prevalence of multiple or large adenomas versus single or small 
adenomas with increasing consumption of trans fatty acid.        
 Minimally adjusted prevalence odds ratios comparing the highest to lowest 
consumption of trans fatty acid were 1.60 (95% CIs 0.75, 3.44) for hyperplastic polyps and 
1.74 (95% CIs 0.98, 3.06) for adenomatous polyps.  The estimates from the fully adjusted 
model were less precise but otherwise similar to the minimally adjusted estimates (Table 
4.4).   
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4.5 DISCUSSION 
 
Using data from a large cross-sectional study, we found that the prevalence of 
colorectal adenomas was positively associated with high trans fatty acid consumption. This 
association was not evident with lower levels of consumption, suggesting a possible 
threshold effect.  We also identified a stronger association between high trans fatty acid 
consumption and prevalence of proximal versus distal adenomas when these case subtypes 
were compared with controls though a difference between associations with adenomas 
classified by location could not be firmly established given the precision of our estimates.  
Associations between trans fatty acid consumption and location, size, and number of 
adenomas were imprecise, but were consistently elevated for the highest versus lowest 
quartiles of consumption.  This supports the conclusion that the association is limited to the 
highest versus lowest quartiles of consumption without clear differences in the relationship 
by location, size, or number.   
 It is well established that adenomatous polyps are precursor lesions for colorectal 
cancer.  However, recent evidence suggests that hyperplastic polyps may also have 
malignant potential (30).  In addition, some studies have found that the risk factors for 
adenomatous polyps and hyperplastic polyps are similar.  Smoking (31-33), fiber 
consumption (33, 34), alcohol intake (33, 34), and hormone replacement therapy use (31) 
have all been shown to increase the risk of both hyperplastic and adenomatous polyps.  To 
explore the possibility that high trans fatty acid consumption is associated with both types of 
polyps, we estimated associations with adenomas and hyperplastic polyps separately.  The 
number of subjects within each quartile of consumption for this analysis was small, but point 
    55 
estimates were elevated for the fourth quartile of consumption, without clear differences 
between histologic subtypes.  Further work with larger sample sizes need to be performed 
before a definitive conclusion can be drawn.   
Previous studies have generally not reported an association between total fat 
consumption and adenoma development.  Randomized trials of a low-fat, high-fiber diet 
found no association between recurrent colorectal adenomas and total fat intake using intent-
to-treat analyses (35, 36).  Two earlier observational studies found associations between 
colorectal adenomas and higher total fat consumption (37, 38), but other observational 
studies have not confirmed this association.  Using data from one of the above randomized 
trials (36), Cantwell et al estimated the association between what people actually reported 
consuming and the risk of recurrent adenomas using the food records collected during the 
intervention (39).  There was no increase in the risk of recurrent colorectal adenomas with 
increasing consumption of total or saturated fats (39).  Another study performed a similar 
analysis and also found no association between total fat intake and recurrent colorectal 
adenomas (40).   
 We hypothesized that specific types of fatty acids, rather than the overall amount, 
may be important in determining disease risk, and therefore, investigated the relationship 
between trans fatty acid intake and colorectal adenomas.  Two prior studies also examined 
the relationship between trans fatty acids and colorectal adenomas (41, 42).  In these studies 
investigators looked at the association between risk of colorectal adenomas and groups of 
foods that contain partially hydrogenated vegetable oils.  Both studies reported a weak 
association between colorectal adenomas and high consumption of sweetened baked goods, 
but the authors concluded that there was no overall association between colorectal adenomas 
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and consumption of partially hydrogenated vegetable oils.  Only one of these studies went 
further and investigated the association between colorectal adenomas and amount of trans 
fatty acid (categorized in intervals of two grams per day); there was no association after 
adjustment for confounding (41).  However, in that study, because cases and controls were 
classified based on sigmoidoscopy results, it is possible that cases with adenomas in the 
proximal colon were misclassified as controls.  In addition, if trans fatty acids differentially 
affect the proximal and distal sections of the colon, then results of the studies based on 
sigmoidoscopy will differ from those investigating adenomas of the entire colon.   
 This study has important strengths.  First, every participant underwent complete 
colonoscopy to the cecum, increasing the likelihood that all visible adenomas were 
enumerated and there was no misclassification of case-control status.  The study had a high 
response rate.  Dietary data were collected using a validated FFQ.  In addition, all colorectal 
adenoma pathology slides were reviewed by a single experienced GI pathologist, and 
reliability was evaluated and found to be good.     
There are some limitations to the present study.  First, results may not be 
generalizable to other populations since individuals going to UNC Hospitals for screening 
colonoscopies are not representative of the general population.  However, previous reports 
using data from similar populations have identified associations that are supported by other 
studies.  For example, in the Diet and Health Study III population NSAID use was inversely 
associated colorectal adenomas (29), which is consistent with two randomized control trials 
that reported associations between recurrent colorectal adenomas and aspirin use (27, 28).  
Other limitations are the relatively small size of the study population and the possibility that 
the people who participated in the study are different than those who refused.  Also, DHQ-
    57 
based estimates of trans fatty acid consumption have not been validated.  Finally, trans fatty 
acid consumption may not be directly related to colorectal adenoma risk, but may instead be 
acting as a proxy for unhealthy behaviors.  We attempted to decrease this bias by controlling 
for other characteristics that are associated with unhealthy behaviors (energy intake, 
physical activity, and alcohol consumption).  
 In conclusion, we found that the highest quartile of trans fatty acid consumption in 
our study population was positively associated with colorectal adenoma prevalence.  These 
results provide further support for recommendations to limit consumption of trans fatty 
acids.   
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4.6 TABLES 
 
 
 
TABLE 4.1.  Characteristics of the Diet and Health Study IV population by case status, NC, 
November 2001-December 2002 (N=622) 
Participant Characteristics Colorectal 
Adenoma 
 (n=173) 
No Colorectal 
Adenoma 
 (n=449) 
Age (%)*   
 30-49 years 28 (16.38) 98 (21.88) 
 50-59 years 82 (47.95) 193 (43.08) 
 60-69 years 39 (22.81) 116 (25.89) 
 70-80 years 22 (12.87) 41 (9.15) 
  
  
 Mean years (SD) 56.96 (9.60) 55.95 (9.86) 
    
Sex (%)   
 Men 98 (56.65) 172 (38.31) 
 Women 75 (43.35) 277 (61.69) 
   
Race (%)*   
 White 133 (77.78) 349 (78.25) 
 Non-White  38 (22.22) 97 (21.75) 
   
Highest level of education (%)*   
 Some high school 24 (14.04) 40 (8.93) 
 High School 27 (15.79) 72 (16.07) 
 Some college 30 (17.54) 95 (21.21) 
 College degree or above 90 (52.63) 241 (53.80) 
   
Body Mass Index 1 year prior to 
enrollment (%)*   
 Normal (18-24.9 kg/m2) 53 (32.92) 174 (42.03) 
 Overweight (25-29.9 kg/m2) 58  (36.02) 140 (33.82) 
 Obese (≥30 kg/m2) 50 (31.06) 100 (24.15) 
    
 Mean  kg/m2 (SD) 28.15 (5.82) 27.00 (5.54) 
   
Current  Physical Activity (MET-
minutes/day) *   
 1st quartile 41 (26.11) 106 (24.65) 
 2nd quartile 37 (23.57) 110 (25.58) 
 3rd quartile 34 (21.66) 113 (26.28) 
 4th quartile 45 (28.66) 101 (23.49) 
    
 Mean MET-minutes/day (SD) 2670.47 (845.85) 2591.08 (754.79) 
   
Smoking status (%)*   
 Never 80 (47.06) 229 (51.12) 
 Former 63 (37.06) 171 (38.17) 
 Current 27 (15.88) 48 (10.71) 
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Family History (%)   
 Yes 27 (15.61) 59 (13.14) 
 No 146 (84.39) 390 (86.86) 
   
NSAID use over the past 5 years (%)*   
 Regular User† 50 (29.76) 124 (28.51) 
 Non-regular User† 118 (70.24) 311 (71.49) 
   
Trans Fat Consumption   
 Mean grams/day (SD) 4.97 (3.20) 4.42 (3.16) 
   
Total Energy Intake    
 Mean kcal/day (SD) 2084.74 (1037.18) 1958.67 (917.30) 
   
Calcium Consumption    
 Mean milligrams/day (SD) 796.42 (442.11) 820.72 (467.44) 
   
Alcohol Consumption*   
 Mean grams/day (SD) 12.49 (20.98) 8.03 (14.23) 
   
Red Meat Consumption    
 Mean ounces/day (SD) 1.88 (1.57) 1.57 (1.44) 
   
Vegetable Consumption    
 Mean number vegetable 
servings/day (SD) 4.34 (2.40) 4.32 (2.46) 
*Data were missing for: age (n=3), race (n=5), education (n=3), BMI (n=47), physical  
activity (n=35), smoking (n=4), NSAID use (n=19), and alcohol consumption (n=1) 
†Regular user is defined as using NSAIDS at least 15 times/month 
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TABLE 4.2.  Adjusted prevalence odds ratios (95% confidence intervals) of quartiles of trans fatty acid 
intake with colorectal adenoma prevalence, Diet and Health Study IV, November 2001-December 2002 
 Minimally Adjusted Model (N=614)†  Fully  Adjusted Model (N=546)‡ 
Quartiles of 
trans fatty acid 
consumption 
Controls 
N  
Cases  
N POR*  95%CI*  
Controls 
N  
Cases  
N POR*  95%CI* 
1 111 40 1.00   99 35 1.00  
2 111 36 1.01  0.58, 1,75  101 31 0.98 0.53, 1.79 
3 111 32 0.95 0.54, 1.67  98 29 1.07 0.57, 2.00 
4 112 61 1.74 1.06, 2.86  103 50 1.86 1.04, 3.33 
*POR: prevalence odds ratio; 95%CI: 95% confidence interval from logistic regression models 
†Adjusted for age, sex, race, and caloric intake 
‡Adjusted for caloric intake, alcohol consumption, physical activity, race, age, sex, and BMI 
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TABLE 4.3. Adjusted prevalence odds ratios (95% confidence intervals)† for location, number, and size of adenomas 
for quartiles of trans fatty acid consumption, Diet and Health Study IV, November 2001-December 2002 
 
Location of Adenomas‡ 
Proximal Adenomas  Distal Adenomas   Quartiles of 
consumption 
 Controls 
N N  POR* 95%CI* N POR* 95%CI* 
 1 99 11 1.00  15 1.00  
 2 101 14 1.23 0.50, 3.07 14 1.13 0.49, 2.61 
 3 98 9 0.94 0.34, 2.59 13 1.16 0.49, 2.75 
 4 103 21 2.80 1.14, 6.87 21 1.51 0.68, 3.35 
 
Number of Adenomas 
1 Adenoma  > 1 Adenoma   Quartiles of 
consumption 
Controls 
N N POR* 95%CI* N POR* 95%CI* 
 1 99 22 1.00  13 1.00  
 2 101 23 1.09 0.55, 2.19 8 0.74 0.28, 1.97 
 3 98 20 1.08 0.52, 2.23 9 1.04 0.39, 2.77 
 4 103 34 1.79 0.91, 3.53 16 2.01 0.83, 4.87 
 
Size of Adenomas§ 
Adenomas <1 cm  Adenomas ≥1 cm   Quartiles of 
consumption 
Controls 
N N POR 95%CI* N POR 95%CI* 
 1 99 27 1.00  7 1.00  
 2 101 26 1.08 0.56, 2.07 5 0.69 0.20, 2.36 
 3 98 24 1.16 0.58, 2.28 5 0.79 0.22, 2.80 
 4 103 37 1.81 0.96, 3.44 13 2.01 0.69, 5.81 
 
 
    
62
*POR: prevalence odds ratio; 95%CI: 95% confidence interval; cm: centimeter 
† Adjusted for caloric intake, alcohol consumption, physical activity, race, age, sex, and BMI 
‡ Adenomas were classified as proximal if they were detected in the cecum, ascending colon, hepatic flexure, or transverse  
colon and distal if present in the splenic flexure, descending colon, sigmoid colon, or rectum.  Participants with 
adenomas in both the proximal and distal colon were excluded from this analysis (n=30).   
§ Size of adenoma was classified based on the size of the largest adenoma detected 
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TABLE 4.4. Adjusted prevalence odds ratios (95% confidence intervals) for quartiles of trans fatty acid intake in association 
with hyperplastic and adenomatous polyp† prevalence, Diet and Health Study IV, November 2001-December 2002 
Minimally Adjusted‡ Fully Adjusted§ 
Controls Hyperplastic  Polyps Adenomatous Polyps Controls Hyperplastic  Polyps Adenomatous Polyps 
Quartiles of 
consumption N N  POR* 95%CI* N POR* 95%CI* N N POR* 95%CI* N POR* 95%CI* 
1 97 14 1.00  30 1.00  88 11 1.00  26 1.00  
2 91 20 1.49 0.69, 3.22 28 1.05  0.57, 1.95 84 17 1.46   0.60, 3.57 24 1.00 0.49, 2.04 
3 93 18 1.37 0.62, 3.03 20 0.79  0.40, 1.53 83 15 1.43  0.55, 3.71 18 0.80  0.36, 1.75 
4 92 20 1.60 0.75, 3.44 44 1.74  0.98, 3.06 83 20 1.93  0.77, 4.85 35 1.66  0.80, 3.43 
*POR: prevalence odds ratio; 95%CI: 95% confidence interval 
†Cases were categorized as having either hyperplastic or adenomatous polyps.  Participants with both were excluded from this  
analysis (n=50) 
‡Adjusted for age, sex, race, and caloric intake 
§Adjusted for caloric intake, age, sex, race, alcohol consumption, physical activity, BMI, smoking status, red meat intake,  
vegetable intake 
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5. RESULTS PAPER 2: Associations between Trans Fatty Acid 
Consumption and Colon Cancer among Whites and African Americans in 
the North Carolina Colon Cancer Study I 
 
 
5.1 ABSTRACT 
 
Background: Colon cancer is one of the most common cancers in the United States.  
Disparities in both incidence and mortality rates exist between Whites and African 
Americans. Prior studies have examined the association between trans fatty acid 
consumption and colorectal cancer, but none have looked at this relationship within a large 
study population of African Americans and Whites. Methods: Using data from a population-
based case-control study in North Carolina, we investigated the association between trans 
fatty acid consumption and colon cancer, with attention to possible racial differences in the 
relationship. Cases and matched controls were queried on demographic characteristics, 
lifestyle factors, medical history, and diet (using the Block Food Frequency Questionnaire). 
Results: Cases reported a higher daily consumption of trans fatty acids intake per day than 
controls [mean (standard deviation) and median: cases 5.9 (2.9) and 5.5 grams/day; controls 
5.2 (2.4) and 4.7 grams/day, respectively].  Energy-adjusted trans fatty acid consumption 
was not associated with colon cancer; compared to participants in the lowest quartile of 
trans fatty acid consumption, those in the highest quartile had an adjusted odds ratio of 1.01 
(95% confidence interval 0.69, 1.49) for Whites and 0.99 (95% confidence interval 0.61, 
1.62) for African Americans. We further investigated tumor location and found no 
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association with increased consumption of trans fatty acid in either the proximal or distal 
colon. We conclude that trans fatty acid consumption is not associated with colon cancer. 
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5.2 INTRODUCTION 
 
 Colorectal cancer is one of the most common cancers in the United States.  Rates of 
both incidence and mortality vary by race.  In the United States the age-adjusted  incidence 
rate for colorectal cancer is 70.2/100,000 for African American men compared to 
63.7/100,000 for White men.  The disparity is seen in women too, with African American 
women having an age-adjusted incidence rate of 53.5/100,000 compared to 45.9/100,000 in 
White women (1).     
The etiology of colorectal cancer is thought to be due largely to environmental 
factors, including diet.  Migrant studies have shown that, with increasing duration of 
residence, migrants have rates of colorectal cancer similar to those of their adopted country 
(2, 3).  Diet is thought to be one of the strongest environmental risk factors for colorectal 
cancer (4, 5).  In a recent report from the World Cancer Research Fund and American 
Institute for Cancer Research, a panel concluded that consumption of red and processed 
meats and alcohol are likely to increase the risk of colorectal cancer (6).   
Although socioeconomic factors and differential screening rates between African 
Americans and Whites may partly explain the disparity in colorectal cancer incidence, diet 
may play a role as well.  Previous research using the North Carolina Colon Cancer Study I 
found that African Americans and Whites have different consumption patterns for various 
groups of foods (7).  One of the components of diet that differed between these races was 
“fats, oils, and snacks,” with African Americans having a higher mean daily intake than 
Whites.  This category included unsaturated, saturated, and trans fatty acids.  Other reports 
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from this study showed similar mean daily intakes of total fat and saturated fatty acids for 
Whites and African Americans (8). 
Total dietary fat has previously been postulated to affect the risk of developing 
colorectal cancer but the majority of studies have shown no association (9, 10).  It is 
possible, however, that it is not overall fat consumption but perhaps specific fat subtypes 
that may be relevant to the etiology of colon cancer.  Recently there has been concern over 
the health effects of trans fatty acid consumption.  Trans fatty acids have been linked to 
increased risk of heart disease (11) and potentially type II diabetes (12).  Although a few 
studies examined the risk of colorectal cancer associated with trans fatty acid consumption 
(13-16), none has looked at this relationship within a large population of African Americans 
and Whites.  If trans fatty acid consumption does play a role in increasing the risk of 
colorectal cancer, it is possible that differential consumption patterns between Whites and 
African Americans may account for some of the disparity in colorectal cancer incidence 
rates.   
The objectives of this study were to examine the associations of trans fatty acid 
consumption and colon cancer both overall and by location.  This study contributes to the 
existing body of knowledge by exploring possible differences in the association by race.   
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5.3 MATERIALS AND METHODS 
 
 The North Carolina Colon Cancer Study I (NCCCS I) was a large population-based 
case-control study conducted in central North Carolina.  It enrolled subjects from 33 
counties, representing urban, suburban, and rural areas of the state.  The study was approved 
by the Institutional Review Board at the University of North Carolina School of Medicine.     
 
5.3.1 STUDY POPULATION 
 Cases were identified using the rapid case ascertainment system of the North 
Carolina Central Cancer Registry.  Those patients with a first diagnosis of histologically 
confirmed invasive adenocarcinoma of the colon between October 1996 and September 
2000 were classified as potential cases.  Additional eligibility requirements were as follows: 
aged 40-80 years, residence in one of the 33 study counties, able to give informed consent, 
able to complete an interview, had a North Carolina driver’s license or identification card (if 
under the age of 65) , and have received no denials from their primary physician for us to 
contact them.   
 Potential cases received a call from a race-matched enrollment specialist, who 
explained the study and scheduled an in-person interview with the patient once consent had 
been obtained.  On average, interviews took place within five months of the participant’s 
diagnosis.  White cases were under-sampled for recruitment in order to increase the 
proportion of non-White cases in the study population. 
 Controls were selected from two sources: the North Carolina Department of Motor 
Vehicles records (for participants under the age of 65) and the Center for Medicare and 
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Medicaid Services (previously the Health Care Financing Administration) records (for those 
65 years and older).  Potential controls were contacted in a manner similar to that of the 
cases.  Controls were matched to cases using randomized recruitment strategies (17) with 
recruitment probabilities defined according to strata of 5-year age, sex, and race groups.   
 
5.3.2 DATA COLLECTION 
 Interviews were conducted by trained nurse interviewers at the participant’s 
residence or another convenient location.  Participants were asked questions about 
demographic information, lifestyle factors, medical history, and diet.  Physical activity was 
measured for occupational, non-occupational, and non-work/weekend activities using a 
modified version of a seven-day physical activity recall (18-20).  Frequency, intensity, and 
duration was estimated and converted into a variable estimating MET minutes per day.  
Interviewers also measured the height and weight of each participant.  They recorded the 
participant’s self-reported weight for one year prior in order to capture weight prior to 
illness or cancer therapy for cases.  Both cases and controls were offered a $25 incentive for 
participation in the study.   
 
5.3.3 DIETARY INFORMATION 
 Dietary information was collected using a modified version of the 100-item 
semiquantitiative Block Food Frequency Questionnaire (21).  Twenty-nine foods commonly 
consumed in North Carolina were added to the questionnaire to offer local cuisine choices to 
participants.  Each food item had three choices for portion size (given as “small,” “medium,” 
and “large”) and nine choices for frequency (ranging from “never or less than once per 
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month” to “2+ times per day”).  When estimating frequency and portion size, study 
participants were asked to use a reference period of the year prior to diagnosis (for cases) or 
interview (for controls) so that seasonal variations in diet could be captured.  Additional 
questions were asked about the following: types of foods/oils used in cooking and 
preparation techniques, fats used in cooking, fortified beverage consumption, low-fat food 
consumption, and restaurant eating. 
 The version of the Block food frequency questionnaire that we used did not contain 
nutritional information on trans fatty acids for any of the foods it included.  Therefore, with 
the help of the Clinical Nutrition Research Center at the University of North Carolina, we 
paired each food listed in the Block FFQ with foods listed in the National Cancer Institute’s 
Diet History Questionnaire (DHQ).  We assigned the amount of trans fatty acid listed for 
each food in the DHQ to the corresponding food in the Block FFQ (per 100 grams of food).  
If more than one DHQ food matched, we applied the mean amount of trans fatty acids for 
those foods to the corresponding Block FFQ food.  Of the 201 Block FFQ foods, 176 
(87.6%) were matched to foods in the DHQ.  For the remaining foods, we searched for trans 
fatty acid values in the USDA National Nutrient Database for Standard Reference (Release 
19) and eight more foods were assigned values (4.0% of all foods).  We were unable to 
determine the amount of trans fatty acid in 17 foods (8.5%), which were assigned values of 
0 grams of trans fatty acid.  We employed the same methods to estimate energy intake.  One 
hundred percent of the Block FFQ foods were matched and assigned caloric values.  The 
original values for caloric intake present in the Block FFQ and the values determined using 
the DHQ and USDA databases were highly correlated (correlation was greater than 0.99).      
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5.3.4 DATA ANALYSIS 
We excluded participants with extreme or implausible values for energy intake [men: 
total kcal/day <800 or >5000 (n=10); women: total kcal/day <600 or >4000 (n=21)].  In 
addition, participants that self-reported their race as “other” were removed from further 
analyses (n=11).   
We energy-adjusted the variable of trans fatty acid using the residual method with 
energy intake as the independent variable and trans fatty acid intake as the dependent 
variable (22, 23).  This allowed us to investigate the association between trans fatty acid 
consumption and colon cancer independent of the amount of energy consumed.  In addition, 
energy adjustment removes potential variation contributed to the association by total energy 
intake (22).  This method is often used for continuous nutrient values but is also an 
acceptable method of energy adjustment when the nutrient values are categorized (23).  
Residuals of trans fatty acid consumption were then divided into quartiles based on the 
distribution of consumption in the control population.   
 Unconditional logistic regression models were used to examine the relationship 
between colorectal cancer and trans fatty acid consumption.  In all models, we included an 
offset term to account for the randomized recruitment sampling fractions (17).  Highest 
educational level achieved (dichotomized as high school or less, more than high school), 
sex, and non-steroidal anti-inflammatory drug (NSAID) use (dichotomized as never/rare 
use, frequent use) were assessed as potential effect measure modifiers using tests of 
homogeneity and likelihood ratio tests with an a priori p-value cut-off of 0.15.  Similar 
studies found that the relationship between trans fatty acid consumption and 
colon/colorectal cancer varied by sex (15, 16) and NSAID use (15).  Previous research has 
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shown NSAID use to be inversely associated with colon cancer (24).  NSAIDs could affect 
the association between trans fatty acid consumption and colon cancer if inflammation 
resulting from trans fatty acid consumption (25) affects the development of colon cancer.  
Highest level of education achieved was used as a proxy for socioeconomic status, as 
individuals with low socioeconomic status may have less access fresh foods (resulting in 
higher consumption of trans fatty acids).  None of these were found to be odds ratio 
modifiers and interaction terms were not retained in the final models.  Using the 10% 
change-in-estimate criterion with backwards elimination, we assessed the following 
variables, which have previously been found to be associated with colorectal cancer and 
which may be associated with trans fatty acid consumption, as potential confounding 
variables: family history of colorectal cancer (yes, no), body mass index (BMI) one year 
prior (normal, overweight, obese according to the World Health Organization cut-points), 
physical activity (quartiles based on the control group), NSAID use (never, occasional, or 
regular), smoking status (never, former, current), highest level of education achieved (high 
school degree or less, some college, college degree or higher), alcohol consumption (none, 
one or fewer drinks/day, more than 1 drink/day),  and calcium consumption, red meat 
consumption, and total vegetable serving consumption (quartiles based on the control 
groups).  All models also included a term for the matching factors (five-year age and sex 
stratum) as well as total energy intake.  We found that the only confounder of the energy-
adjusted model was calcium intake; therefore, it was included with total energy intake, the 
matching factors, and the offset term in the final model.    
 We further explored the relationship between trans fatty acid consumption and 
colorectal cancer by examining risk by location of the cancer.  Cases were categorized as 
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having proximal tumors if the cancer was present in the cecum, ascending colon, hepatic 
flexure, or transverse colon.  Cancers were considered distal tumors if they were present in 
the splenic flexure, descending colon, or sigmoid colon.  Cases with unspecified tumor 
locations or overlapping lesions were excluded from this analysis (n=59).  We estimated 
these associations using multinomial logistic regression and reevaluated potential odds ratio 
modifiers and confounders using the aforementioned criteria.  Due to the limitations of 
multinomial logistic regression, we were not able to include an offset term with theses 
models.  Alcohol consumption and calcium intake were confounders of the energy-adjusted 
model based on our change-in-estimate criterion and were included in the energy-adjusted 
model with the matching factors and energy intake.   
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5.4 RESULTS 
 
 Among those who were eligible, reasons for not being interviewed were as follows: 
refusal (14% cases; 36% controls), untraceable (1% cases, 1% controls), not reachable by 
phone (6% cases, 1% controls), and physician denial (7% cases).   Completed interviews 
were obtained for 1691 participants (643 cases, 1048 controls).  The rate of study 
cooperation (interviewed/(interviewed+refused)) was 84% for cases and 63% for controls. 
Response rates (interview/eligible) for cases and controls were 72% and 61%, respectively.  
Excluding the aforementioned participants with implausible dietary values or self-reported 
“other” race, our final study population included 623 cases (341 Whites and 282 African 
Americans) and 1020 controls (606 Whites and 414 African Americans). 
 Characteristics of the study population are given in Table 5.1.  The majority of the 
study population was over 60 years old with less than a college degree.  The proportion in 
both cases and controls of participants with a high school degree or less was greater among 
African Americans than Whites (cases: 72.3% versus 57.1%; controls: 69.1% versus 
48.8%).  Overall, cases had a higher mean BMI than controls [29.4 (standard deviation: 6.1) 
versus 28.4 (standard deviation: 5.8), respectively].  The proportion of African American 
cases and controls classified as overweight or obese (BMI of 25 kg/m2 or higher) one year 
prior to diagnosis/interview was greater than the proportion of White cases and controls, 
respectively.  Cases of both races were more likely to have a family history of colorectal 
cancer.  Both Whites and African American cases reported higher total energy intake than 
their respective controls, and total energy intake was found to be associated with colon 
cancer among both races.  This was demonstrated using a t-test as well as a logistic 
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regression model controlled for other potential covariates [p-values<0.01 for tests among 
both Whites and African Americans; logistic regression results for 100 kcal units of total 
energy intake: Whites 1.05 (95% CI 1.02, 1.08), African Americans 1.05 (95%CI 1.02, 
1.07)].  Also, trans fatty acid consumption and total energy intake were correlated 
(correlation>0.80 overall and among Whites and African Americans).   
 Cases also had a higher mean daily intake of trans fatty acid than controls.  White 
cases reported a mean (standard deviation) and median (interquartile range) trans fatty acid 
consumption of 5.9 (2.7) and 5.5 (3.9, 7.3) grams per day compared with 5.2 (2.4) and 4.8 
(3.5, 6.4) grams per day for White controls (p-values: t-test <0.01; Wilcoxon rank-sum test 
<0.01).  The mean (standard deviation) and median (interquartile range) for African 
Americans was 6.1 (3.2) and 5.4 (3.7, 7.5) grams per day among cases and 5.2 (2.6) and 4.7 
(3.5, 6.4) grams per day among controls, respectively (p-values: t-test <0.01; Wilcoxon 
rank-sum test <0.01).  Although African American cases had a higher mean daily intake of 
trans fatty acids compared to White cases, statistically these values were not different (p-
value 0.34).   
 Prior to adjustment for energy intake, colon cancer was positively associated with 
high trans fatty acid consumption.  Odds ratios adjusted for confounding factors other than 
energy intake comparing the fourth quartile with the first quartile of trans fatty acid 
consumption were 2.01 (95% CI: 1.22, 3.30) for Whites and 2.50 (95% CI: 1.40, 4.47) for 
African Americans (Table 5.2).  This relationship did not persist in energy-adjusted 
analyses.  The adjusted odds ratios for the fourth quartiles of consumption compared with 
the lowest quartiles were 1.01 (95% CI: 0.69, 1.49) and 0.99 (95% CI: 0.61, 1.62) for 
Whites and African Americans, respectively (Table 5.2).     
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 In addition, we investigated cancer in the proximal and distal colon separately to 
determine if the relationship between trans fatty acid consumption and cancer differed by 
location (Table 5.3).  There was no association present for proximal or distal colon cancer in 
relation to increased trans fatty acid consumption.  Among Whites, the adjusted odds ratio 
(95% confidence interval) for the highest quartile compared to the lowest quartile of intake 
were 1.05 (95% CI: 0.60, 1.83) and 0.92 (95% CI: 0.55, 1.56) for the proximal and distal 
colon, respectively.  These results were 1.35 (95% CI: 0.71, 2.55) and 0.69 (95% CI: 0.36, 
1.31), respectively, among African Americans.   
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5.5 DISCUSSION 
 
In this population-based case-control study of colon cancer in North Carolina, trans 
fatty acid consumption was not associated with colon cancer in either Whites or African 
Americans.  In addition, the association did not differ between proximal or distal cancer 
locations.  The point estimate for the highest quartile of trans fatty acid was greater for the 
proximal colon compared with the distal colon among African Americans, but due to a lack 
of precision we were unable to establish whether high trans fatty acid consumption was 
truly related to cancer in this section of the colon.   
The greater consumption of “fats, oils, and snacks” by African Americans in 
comparison to the consumption by Whites previously illustrated in our research (7) is not 
likely to be due to trans fatty acid consumption. Whites and African Americans in this study 
had similar daily intakes of trans fatty acids.   Moreover, the absence of an association 
between trans fatty acid consumption and colon cancer, combined with the similarity in 
trans fatty acid consumption between the races, makes it unlikely that trans fatty acid 
consumption contributes to the disparity in colon cancer rates observed between Whites and 
African Americans.   
 Thus far, results of studies examining the association between colorectal cancer and 
trans fatty acid consumption have been mixed.  Three previous case-control studies 
investigated the association between trans fatty acid consumption and colon (15) and 
colorectal cancer (14, 16).  One demonstrated that higher consumption was positively 
associated with colon cancer for post-menopausal women not on hormone replacement 
therapy (15) and another found an elevated relative risk among women, in general (16).  
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There was no association among men in either study (15, 16).  The other case-control study 
also showed no association between colorectal cancer and trans fatty acid consumption (14).  
A cohort study, the Women’s Health Study, also examined trans fatty acid consumption but 
found no association (13).  No previous studies to which we could compare our results have 
examined the relationship between trans fatty acid consumption and colon cancer in a large 
population of African Americans.     
 We have previously shown that high consumption of trans fatty acid is associated 
with higher prevalence of colorectal adenomas (unpublished).  Other studies of adenomas 
have found no association (26, 27).  Trans fatty acids may work to increase the risk of 
colorectal adenomas by altering the concentration of fat and bile normally found in the colon 
(28),thereby irritating the colonic mucosa and resulting in increased oxidative stress (29) and 
inflammation (25).  In addition, some studies have shown that colonic bacteria metabolize 
bile acids to form compounds that are carcinogenic and increase cellular proliferation (9, 30-
32).  Trans fatty acids may also affect insulin resistance (12, 33, 34), which could lead to 
increased cellular proliferation (35, 36).  It is plausible that these mechanisms bring about 
changes in the mucosa that result in the formation of adenomas but that trans fatty acid 
consumption does not affect the transition from adenoma to cancer in the colon.  Other 
studies have also found certain exposures to be associated with colorectal adenomas but not 
with cancer.  Despite the lack of association between trans fatty acid consumption and colon 
cancer in our study, if trans fatty acids have a moderate affect on developing colorectal 
adenomas, we expect that the current reductions in the amount of trans fatty acids in the 
food supply, via voluntary removal from food products and bans in the commercial food 
outlets of certain localities, will favorably affect the rates of colon cancer.   
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 The present study has many strengths, one of which is that we performed in-depth in-
person interviews.  In addition, we had a large number of African Americans in the study 
population, a group that has not been examined with respect to trans fatty acid consumption 
and colon cancer.  There are limitations to the study as well.  We did not have trans fatty 
acid values for all of the foods options present in the Block Food Frequency questionnaire.  
For example, fried chicken can be classified as homemade or restaurant-made.  These may 
have different amounts of trans fatty acid but we assigned them the same value.  This is 
unlikely to have greatly affected our results as it was a small number of foods contributing 
to only a minor part of participant’s reported diets.  The mean grams per day of trans fatty 
acid reported in our study is similar to that seen in similar studies, thereby validating our 
assignment of trans fatty acid values.   
 In conclusion, using data from a large case-control study, we found no association of 
trans fatty acid consumption with colon cancer in either Whites or African Americans.  
Based on these results, it is unlikely that trans fatty acid intake contributes to racial 
disparities in colon cancer incidence.   
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5.6 TABLES 
 
TABLE 5.1.  Characteristics of the North Carolina Colon Cancer Study I (NCCCS I) population by case status 
and race, NC, 1996-2000 
 
Participant Characteristics       Whites (n=947) 
African-Americans 
 (n=696) 
  Cases  
(n=341) 
Controls 
(n=606) 
Cases 
 (n=282) 
Controls 
(n=414) 
Age (%)     
 <50 27 (7.92) 34 (5.61) 37 (13.12) 25 (6.04) 
 50-59 66 (19.35) 108 (17.82) 73 (25.89) 81 (19.57) 
 60-69 117 (34.31) 206 (33.99) 92 (32.62) 129 (31.16) 
 >70 years 131 (38.42) 258 (42.57) 80 (28.37) 179 (43.24) 
 Mean years (SD) 65.06 (9.70) 66.16 (9.30) 62.04 (10.32) 65.94 (9.63) 
Sex (%)     
 Men 190 (55.72) 328 (54.13) 135 (47.87) 181 (43.72) 
 Women 151 (44.28) 278 (45.87) 147 (52.13) 233 (56.28) 
Education (%)     
 ≤ High School 194 (57.06) 296 (48.84) 204 (72.34) 286 (69.08) 
 Some college 69 (20.29) 148 (24.42) 50 (17.73) 73 (17.63) 
 College graduate/advanced 
degree 
77 (22.65) 162 (26.73) 28 (9.93) 55 (13.29) 
Body Mass Index 1 year prior to 
enrollment (%)* 
    
 Normal (18-24.9 kg/m2) 95 (28.53) 190 (31.99) 44 (15.94) 81 (20.72) 
 Overweight (25-29.9 kg/m2) 139 (41.74) 250 (42.09) 113 (40.94) 145 (37.08) 
 Obese (>=30 kg/m2) 99 (29.73) 154 (25.93) 119 (43.12) 165 (42.20) 
 Mean  kg/m2 (SD) 28.37 (5.62) 27.57 (5.15) 30.07 (6.52) 29.73 (6.50) 
Physical Activity (MET-
minutes/day) (mean, %)* 
    
 1st quartile 64 (18.93) 121 (20.17) 73 (27.24) 131 (32.11) 
 2nd quartile 87 (25.74) 151 (25.17) 62 (23.13) 102 (25.00) 
 3rd quartile 95 (28.11) 175 (29.17) 59 (22.01) 76 (18.63) 
 4th quartile 92 (27.22) 153 (25.50) 74 (27.61) 99 (24.26) 
 Mean MET-minutes/day 
(SD) 
2261.46 
(565.66) 
2199.71 
(450.66) 
2229.19 
(566.56) 
2154.99 
(533.56) 
Smoking status (%)     
 Never 115 (33.92) 243 (40.10) 133 (47.50) 188 (45.41) 
 Former 180 (53.10) 267 (44.06) 91 (32.50) 143 (34.54) 
 Current 44 (12.98) 96 (15.84) 56 (20.00) 83 (20.05) 
Family History (%)     
 Yes 74 (21.83) 57 (9.48) 47 (16.67) 43 (10.41) 
 No 265 (78.17) 544 (90.52) 235 (83.33) 370 (89.59) 
 
NSAID use over the past 5 years 
(%)† 
    
 Never 38 (11.18) 43 (7.10) 32 (11.35) 31 (7.49) 
 Occasionally 128 (37.65) 173 (28.55) 123 (43.62) 133 (32.13) 
 Regularly 174 (51.18) 390 (64.36) 127 (45.04) 250 (60.39) 
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*Data were missing for: Education (n=1), BMI (n=49), physical activity (n=29), smoking status (n=4) and  
family history (n=8), NSAID use (n=1) 
† Non-steroidal anti-inflammatory drug (NSAID) use is defined as Never for subjects who reported no use,  
Occasional for subjects who reported some use but use less than 15 times/month, and Frequent for subjects 
who reported use at least 15 times/month
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trans Fat Consumption 
    
Mean grams (SD) 5.85 (2.69) 5.17 (2.35) 6.07 (3.15) 5.20 (2.56) 
Total Energy Intake  
    
Mean grams (SD) 1951.58 
(689.12) 
1784.01 
(599.53) 
1940.41 
(832.11) 
1697.62 
(652.52) 
Calcium Consumption  
    
Mean grams (SD) 721.10 
(340.21) 
755.93 
(349.77) 
615.97 
(342.40) 
577.03 
(280.37) 
Alcohol Consumption  
    
0 drinks/day 209 (61.29) 361 (59.57) 220 (78.01) 334 (80.68) 
>0 and ≤1 drink/day 81 (23.75) 182 (30.03) 38 (13.48) 67 (16.18) 
>1 drink/day 51 (14.96) 63 (10.40) 24 (8.41) 13 (3.14) 
Red Meat Consumption  
    
 Mean ounces (SD) 139.00 (94.96) 118.33 (80.06) 122.77 (85.56) 104.14 
(77.85) 
Vegetable Consumption 
    
 Mean servings (SD) 231.99 
(107.13) 
251.94 
(123.00) 
188.92  
(117.43) 
191.40 
(105.37) 
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TABLE 5.2. Odds ratios (95% confidence intervals)* of quartiles of non-energy adjusted and energy adjusted trans fatty acid 
intake with colon cancer risk by race, NCCCS I, 1996-2000 
 
NON-ENERGY ADJUSTED† 
 
 
  
WHITES 
 
AFRICAN AMERICANS 
Quartiles of trans fatty 
acid consumption 
Median grams trans 
fatty acid/day (IQR)  
N 
cases 
N 
controls OR 95% CI  
N 
cases 
N 
controls OR 95% CI 
1 2.70 (2.22, 3.11)  62 140 1.00   57 96 1.00  
2 4.07 (3.76, 4.41)  66 136 1.02 0.65, 1.60  52 104 0.87 0.52, 1.45 
3 5.50 (5.11, 5.91)  77 154 1.10 0.69, 1.77  57 85 1.36 0.79, 2.33 
4 8.04 (7.20, 9.79)  122 144 2.01 1.22, 3.30  105 96 2.50 1.40, 4.47 
 
ENERGY ADJUSTED‡ 
 
  
WHITES 
 
AFRICAN AMERICANS 
Quartiles of trans fatty 
acid consumption 
Median grams 
energy-adjusted trans 
fatty acid/day (IQR) 
 
N 
cases 
N 
controls OR 95% CI  
N 
cases 
N 
controls OR 95% CI 
1 4.26 (3.66, 4.59)  92 173 1.00   53 70 1.00  
2 5.24 (5.07, 5.44)  79 138 1.10 0.74, 1.63  57 108 0.80 0.47, 1.34 
3 5.99 (5.81, 6.19)  69 137 0.87 0.58, 1.32  75 111 1.02 0.62, 1.68 
4 7.12 (6.71, 7.84)  94 138 1.01 0.69, 1.49  91 114 0.99 0.61, 1.62 
*Odds ratio: OR; 95% confidence interval (95%CI); Interquartile Range: IQR 
†Adjusted for age, sex, vegetable consumption, meat consumption, calcium intake, and BMI 
‡Adjusted for age, sex, energy intake, and calcium intake 
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TABLE 5.3. Odds ratios (95% confidence intervals)* of quartiles of non-energy adjusted and energy adjusted trans fatty acid intake 
with colon cancer risk by location and race, NCCCS I, 1996-2000 
WHITES  AFRICAN AMERICANS 
Non-Energy Adjusted† Energy Adjusted‡ Non-Energy Adjusted†  Energy Adjusted‡ 
Quartiles 
of trans 
fatty acid 
consump-
tion§ 
N 
cases 
N 
controls OR 
95% 
CI 
N 
cases 
N 
controls OR 
95% 
CI 
N 
cases 
N 
controls OR 
95% 
CI 
N 
cases 
N 
controls OR 
95% 
CI 
 
 
PROXIMAL COLON 
1 26 140 1.00  42 173 1.00  23 96 1.00  22 70 1.00  
2 34 134 1.15 0.62, 2.15 40 138 1.40 
0.83, 
2.37 25 104 1.08 
0.55, 
2.14 29 108 0.97 
0.49, 
1.90 
3 33 153 1.22 0.63, 2.35 23 137 0.73 
0.40, 
1.35 26 84 1.72 
0.84, 
3.55 24 111 0.77 
0.39, 
1.55 
4 44 144 1.96 0.98, 3.96 35 138 1.05 
0.60, 
1.83 46 96 3.10 
1.45, 
6.63 48 114 1.35 
0.71, 
2.55 
 
 
DISTAL COLON 
1 32 140 1.00  43 173 1.00  31 96 1.00  31 70 1.00  
2 28 134 0.79 0.43, 1.46 35 138 0.96 
0.56, 
1.63 24 104 0.69 
0.36, 
1.33 26 108 0.77 
0.39, 
1.50 
3 37 153 0.96 0.51, 1.80 35 137 0.90 
0.52, 
1.56 25 84 0.93 
0.46, 
1.85 38 111 1.26 
0.68, 
2.33 
4 58 144 1.55 0.81, 2.99 46 138 0.92 
0.55, 
1.56 49 96 1.72 
0.82, 
3.59 28 114 0.69 
0.36, 
1.31 
*Odds ratio: OR; 95% confidence interval (95%CI) 
†Adjusted for age, sex, calcium intake, meat consumption, alcohol consumption, BMI one year prior, and family history of colorectal 
cancer 
‡Adjusted for age, sex, energy intake, calcium intake, and alcohol intake 
§ Median grams trans fatty acid/day (IQR): Non-energy adjusted quartiles: Q1) 2.70 (2.22, 3.11); Q2) 4.07 (3.76, 4.41); Q3) 5.50  
(5.11, 5.91); Q4) 8.04 (7.20, 9.79); Energy adjusted quartiles: Q1) 4.26 (3.66, 4.59); Q2) 5.24 (5.07, 5.44); Q3) 5.99 (5.81, 
6.19); Q4) 7.12 (6.71, 7.84) 
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6. RESULTS PAPER 3: Trans Fatty Acid Consumption and its 
Association with Distal Colorectal Cancer in the North Carolina 
Colon Cancer Study II 
 
6.1 ABSTRACT 
 
Background: Recently, there has been much concern about the effect of trans fatty acid 
consumption on health.  A few studies have looked at the risk of colorectal cancer with 
increased consumption of trans fatty acid, but to our knowledge, none have investigated the 
risk of rectal cancer, which may have different risk factors than colon cancer.   
Methods: We used a large case-control study of Whites (n=1516) and African Americans 
(n=392) in central and eastern North Carolina.  Incident cases of histologically confirmed 
distal colorectal (sigmoid, rectosigmoid, and rectal) cancer (n=950) and controls matched by 
sex, race, and 5-year age groups (n=958) were interviewed about demographic information, 
lifestyle factors, and diet (using the Diet History Questionnaire).   
Results: White cases reported a higher mean consumption of trans fatty acid compared to 
controls (6.1 versus 5.4 grams/day).  The mean consumption of trans fatty acid was similar 
for African American cases and controls (6.3 grams/day).  Relative to the lowest quartile, 
the highest quartiles of energy-adjusted trans fatty acid consumption were positively 
associated with distal colorectal cancer for Whites [adjusted odds ratios for the third and 
fourth quartiles, respectively: 1.45 (95% confidence interval: 1.06, 1.97) and 1.34 (95% 
confidence interval: 0.99, 1.83)].  Trans fatty acid consumption was inversely associated 
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with distal colorectal cancer in African Americans [adjusted odds ratio for the fourth quartile 
compared to the lowest quartile of consumption of 0.54 (95% confidence interval 0.28, 
1.02)].  These associations persisted in the analyses of different types of trans fatty acids.  
Trans fatty acid consumption was not differentially associated with cancer of the sigmoid 
colon, rectosigmoid, or rectum.   
Conclusion: High consumption of trans fatty acids is positively associated with cancer in the 
sigmoid colon, rectosigmoid, and rectum among Whites.   
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6.2 INTRODUCTION 
 
In the United States, colorectal cancer is the third leading cause of cancer death 
among both men and women, accounting for approximately 10% of all cancer deaths each 
year.  It is estimated that in 2007, 112,340 people were diagnosed with colon cancer and 
41,420 people were diagnosed with rectal cancer in the United States (1).  Diet is thought to 
play a large role in the development of colorectal cancer (2).  Total dietary fat has been 
studied as a potential risk factor for colorectal cancer, but no overall association has been 
found (3-9).  It is possible, however, that a specific type of dietary fat may be associated 
with colorectal cancer. For example, the majority of studies agree that saturated fatty acids 
do not affect the risk of colorectal cancer (6, 8, 10, 11).  Other fatty acids, such as, n-3 and 
n-6 polyunsaturated fatty acids have been studied but the results are inconsistent (8, 10, 11).   
Trans fatty acid consumption has been linked to a variety of diseases, including heart 
disease and  type II diabetes (12, 13).  Ecologic studies have demonstrated a relationship 
between trans fatty acids and the rates of prostate, breast, and colon cancer in Europe  (14).  
Therefore, we hypothesized that trans fatty acid might be involved in increasing the risk of 
developing cancers of the colon and rectum.   
Although the majority of etiologic studies combine cancers of the colon and rectum, 
the risk factors for these cancers may be distinct.  In the EPIC study cohort waist 
circumference, waist-hip ratio, and physical activity were positively associated with colon 
cancer but not rectal cancer (15, 16).  These findings were also supported by a review of 
physical activity and cancers of the colon and rectum (17).  Thus far, to our knowledge, no 
studies of trans fatty acid consumption and colorectal cancer have examined associations 
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with cancers of the colon and rectum separately.  Therefore, we used data from the North 
Carolina Colon Cancer Study II to investigate the potential association between 
consumption of trans fatty acids and cancer of the distal colon and rectum.  In addition, we 
investigated whether these associations differed by race.   
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6.3 MATERIALS AND METHODS 
 
6.3.1 STUDY POPULATION 
 The North Carolina Colon Cancer Study II (NCCCS II) is a population-based case-
control study conducted in central and eastern North Carolina.  Subjects were enrolled from 
33 counties, representing urban, suburban, and rural areas of the state.   
 Cases were identified using the rapid case ascertainment system of the North 
Carolina Central Cancer Registry.  Those individuals with a first diagnosis of histologically 
confirmed sigmoid colon, rectosigmoid, or rectal adenocarcinoma between November 2001 
and August 2006 were classified as potential cases.  To be eligible for the study, subjects 
had to be between the ages of 40 and 80, reside in one of the 33 counties included in the 
study, be able to give informed consent, be able to complete an interview, had a North 
Carolina driver’s license or identification card (if under the age of 65), and had no denial by 
the primary physician for us to contact them.   
Potential cases were sent a letter describing the study, which was followed up with a 
call from a race-matched enrollment specialist.  The specialist explained the study and 
answered any questions that the patient had about participating.  If the patient consented, 
then the enrollment specialist scheduled an in-person interview.  On average, interviews 
took place within five months of diagnosis.  White cases were under-sampled for 
recruitment in order to increase the proportion of African American cases in the study 
population. 
 Controls were selected from two sources: North Carolina Department of Motor 
Vehicles records (for controls under the age of 65) and Center for Medicare and Medicaid 
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Services records (for controls age 65 and older).  Randomized recruitment (18) was used to 
sample controls according to the expected age (within 5-year strata), sex, and race 
distribution of the cases.  Potential controls were contacted in a manner similar to that of the 
cases. The same eligibility requirements (with the exception of physician contact) were 
applied to the control population.    
 
6.3.2 DATA COLLECTION 
 Data were collected by trained nurse interviewers at the person’s house or another 
convenient location. Individuals were offered a $25 incentive for participation in the study.  
All participants were asked questions pertaining to demographic information, lifestyle 
factors, and medical history.  Information on physical activity was ascertained using a 
seven-day recall previously validated in a group of men and women aged 20-59 (19-21).  
Height and weight were measured at the interview, and participants were also asked about 
their weight one year prior to diagnosis (for cases) or interview (for controls).     
 Dietary information was collected using the validated Diet and Health Questionnaire 
(DHQ) developed at the National Cancer Institute (22-24).  This food frequency 
questionnaire allows participants to choose both the portion size and frequency of foods that 
they consume and also accounts for differences in cooking methods.  In order to capture 
usual diet across seasons, we asked participants to use a reference period of the year prior to 
cancer diagnosis (for cases) or interview (for controls).  Diet*Calc, a program developed by 
the NCI to accompany the DHQ, was used to determine average daily nutrient intakes, 
including trans fatty acids, for each subject.   
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6.3.3 DATA ANALYSIS 
 Participants who self-identified their race as “other” or were missing information on 
self-identified race were removed from the analysis (n=61).  Participants with extreme or 
implausible dietary values [< 800 or >5000 kcal/day for men (n=74) and <600 or >4000 
kcal/day for women (n=34)] were also excluded from the analysis.   
 We utilized the residual method to measure trans fatty acid consumption adjusted for 
energy intake.  Specifically, the values of each participant’s energy-adjusted intakes were 
estimated based on a regression model in which energy intake was the independent variable 
and trans fatty acid intake was the dependent variable (25).  This allowed us to focus on 
trans fatty acid consumption estimates that were not correlated with energy intake.  Trans 
fatty acid consumption was then categorized into quartiles based on consumption in the 
control group.   
We used unconditional logistic regression to investigate the relationship between 
trans fatty acid consumption and distal colorectal cancer. An offset term was included in all 
models to correct for the randomized recruitment sampling fractions (18).  Non-steroidal 
anti-inflammatory drug (NSAID) use and sex were assessed as potential effect measure 
modifiers, using tests of homogeneity and likelihood ratio tests comparing models with and 
without interaction terms (with an a priori p-value cut-off for retention in the final model of 
less than 0.15).  These variables were chosen because similar studies found that the 
association between trans fatty acid consumption differed within strata of these variables 
(11, 26).  In addition, NSAID use has previously been inversely associated with colon 
cancer (27) and could play a biologic role if trans fatty acid consumption does promote 
inflammation  (28).  Likelihood ratio tests examining NSAID use as an effect measure 
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modifier had p-values of 0.36 in Whites and 0.90 in African Americans.  P-values for the 
likelihood ratio tests examining sex as an effect measure modifier were 0.26 in Whites and 
0.42 in African Americans.  The following variables, which have been previously associated 
with colorectal cancer and may be associated with trans fatty acid consumption, were 
assessed as potential confounders using a 10% change-in-estimate criterion: body mass 
index (BMI) one year prior to diagnosis/interview (normal, overweight, and obese according 
to the World Health Organization cut-points), physical activity (quartiles based on the 
control group), at least one first degree family member with a diagnosis of colorectal cancer 
(yes, no), NSAID use (never, rare, and frequent), smoking status (never, former, and current 
smoker), and daily consumption of calcium (dietary and supplemental), alcohol, vegetables, 
and red meat (quartiles based on the control group).  Although the actual number of missing 
observations was small, multiple imputation was performed to impute data for potential 
confounding variables with more than 0.5% percent missing data (physical activity: 5.2% 
missing, BMI one year prior: 3.7% missing, family history: 2.3% missing, smoking status: 
0.9% missing, and NSAID use: 0.6% missing). Characteristics that met our change-in-
estimate criterion in one or both racial groups [highest level of education completed (in both 
groups), BMI one year prior to interview (in Whites), and family history of colorectal cancer 
(in African Americans)] were included in the final models for both races.  In addition, the 
final model included a term for total energy intake, a term for stratum of matching variable 
(sex and five-year categories of age), and an offset term to account for sampling 
probabilities.   
 In addition, we investigated the relationship between the location of the tumor 
(sigmoid colon, rectosigmoid, or rectum) and trans fatty acid consumption.  Cases without a 
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specified location were excluded from this analysis (n=12).  This analysis was performed 
using multinomial logistic regression, without imputing data for missing covariates, as this 
was not possible with the model we used.  Another limitation of this model is that we were 
not able to include offset terms.  Potential confounders were reassessed for this model using 
a 10% change-in-estimate criterion. 
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6.4 RESULTS 
 
Among those who were eligible to participate in the study, 17% of cases and 26% of 
controls refused and 8% of cases and 18% of controls were untraceable or not reached.   A 
total of 2076 people completed interviews (1057 cases and 1019 controls), yielding study 
cooperation rates (interviewed/(interviewed+refused)) for cases and controls of 81% and 
68% and  response rates (interview/eligible) of 74% and 56%, respectively.   
 Characteristics of the study population are shown according to case-control status 
and race in Table 6.1. Most of the study participants were at least 60 years old.  A larger 
percentage of White and African American cases had a high school degree or less compared 
with controls (19.4 and 35.2% compared with 12.1 and 26.4%, respectively).  Both White 
and African American cases were more likely to be obese compared to controls (36.7 and 
49.5% versus 28.3 and 41.3%, respectively).  Cases had a higher total energy intake 
compared to controls [mean (standard deviation) kcal/day of 2280.5 (855.8) versus 2158.0 
(813.6)].  Within each group of cases and controls, African Americans reported higher total 
energy intake than Whites.  Both t-tests (Whites: p-value 0.02; African Americans: p-value 
0.06) and a logistic regression model using 100  kcal units of total energy intake and 
controlling for possible covariates [Whites: 1.02 (95% CI 1.01, 1.04) p-value 0.01; African 
Americans: 1.03 (95% CI 1.00, 1.06) p-value 0.04] showed total energy intake to be 
associated with distal colorectal cancer.  This association, combined with the determination 
that energy intake was correlated with trans fatty acid consumption (correlation was 0.77 for 
Whites and 0.81 for African Americans) support our use of energy adjustment.   
 101 
White cases had a higher mean intake of unadjusted trans fatty acid than controls 
[mean (standard deviation) grams/day of 6.1 (3.0) and 5.4 (2.9), respectively] (t-test p-value 
<0.01).  The median grams/day (interquartile range) for intake among Whites were 5.6 (3.8, 
7.7) for cases and 4.9 (3.2, 7.0) for controls (Wilcoxon rank-sum test p-value <0.01).  
Intakes were similar among African American cases and controls: a mean of 6.33 for both 
cases and controls (standard deviation of 3.3 and 3.5, respectively) (t-test p-value 0.97).  The 
similarity was also seen for the medians of trans fatty acid consumption (5.7 grams/day; 
Wilcoxon rank-sum test 0.84).  We modeled the association between total trans fatty acid 
intake, prior to energy adjustment and distal colorectal cancer, controlling for variables 
found to be confounders of the non-energy adjusted model (physical activity, education, 
calcium intake, and meat consumption), sex, age, and offset terms.  There was a positive 
relationship between increasing trans fatty acid consumption and distal colorectal cancer for 
Whites.  Odds ratios comparing the second, third, and fourth quartiles to the lowest quartile 
of consumption were 1.66 (95% CI 1.20, 2.31), 1.74 (95% CI 1.22, 2.48) and 2.44 (95% CI  
1.64, 3.65), respectively.   For African Americans the odds ratios were 1.22 (0.59, 2.52), 
1.52 (95% CI 0.68, 3.39) and 0.69 (95% CI 0.30, 1.60), respectively.   
High consumption of trans fatty acids was positively associated with distal colorectal 
cancer for Whites (Table 6.2).  The odds ratios for the energy-adjusted models were slightly 
decreased from those seen in the non-energy adjusted models.  Both the third and fourth 
quartiles of trans fatty acid consumption remained positively associated with distal 
colorectal cancer [third quartile: odds ratio 1.45 (95%CI: 1.06, 1.97); fourth quartile: odds 
ratio 1.34 (95% CI: 0.99, 1.83)].  A similar association was not seen for African Americans 
(Table 6.2) with the odds ratios comparing the third and fourth quartiles to the lowest 
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quartile being 0.72 (95% CI: 0.36, 1.43) and 0.54 (95% CI: 0.28, 1.02), respectively.  A 
priori, we decided to present both combined and race-stratified results.  Therefore, although 
we noted differences in the estimated association by race, the combined results are also 
given in Table 6.2.  The results for the overall study population are 1.31 (95% CI: 0.99, 
1.74) for the third quartile and 1.14 (95%CI: 0.87, 1.51) for the fourth quartile compared 
with the lowest quartile of consumption.  We further examined the relationship looking at 
specific types of trans fatty acid: 16:1 trans-hexadecenoic acid. 18:1trans-octadecenoic 
acid, and 18:2trans-octadecadienoic acid.  The same relationships seen in total trans fatty 
acid consumption were present for each of these in both Whites and African Americans 
(Table 6.2). 
 Finally, we explored the relationships between consumption of trans fatty acids and 
tumor location (sigmoid colon, rectosigmoid, or rectum).  Though the results were more 
imprecise due to smaller numbers in each of the categories, a positive association was seen 
for all three locations with moderate/high consumption of trans fatty acid in Whites.  There 
was a positive but imprecise association between high trans fatty acid consumption (fourth 
quartile) and cancer of the rectosigmoid among African Americans, but only twenty-four 
African Americans had cancer present in this location.  The other tumor sites showed 
inverse associations consistent with those of the combined analysis (Table 6.3).  Overall, 
associations with trans fatty acid consumption did not clearly differ in either racial group 
based on the location of the cancer.  
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6.5 DISCUSSION 
 
 In this study, we found distal colorectal cancer was positively associated with 
consumption of trans fatty acids for Whites.  The two highest quartiles of trans fatty acid 
consumption had the largest increase in relative risk of colorectal cancer.  This was true for 
all types of trans fatty acid (16:1 trans hexadecenoic acid, 18:1 trans octadecenoic acid , 
and, 18:2 trans octadecadienoic acid).  In addition there was no difference in relative risk for 
cancer of the sigmoid colon, rectosigmoid, or rectum. In Whites, increased consumption of 
trans fatty acids was positively associated with cancer for each of these locations.   
 The results of the combined analysis showed a positive association between distal 
colorectal cancer and the third quartile of trans fatty acid consumption compared with the 
lowest quartile, but no association was present in the comparison of the highest to lowest 
quartiles.  In African Americans the association between distal colorectal cancer and 
increased consumption of trans fatty acid was the opposite of what we saw for Whites; 
higher consumption appeared protective.  This was true among all types of trans fatty acid.  
We cannot explain why increased consumption of trans fatty acid is inversely associated 
with distal colorectal cancer in African Americans. It could be the result of sampling error 
among the control population, inaccurate dietary reporting among the controls, or 
confounding by an unknown factor.  It is also possibly a chance finding.  Further work 
should be done examining the association in a large sample of African Americans. 
 Previous studies examined colon or colorectal cancer in association with trans fatty 
acid consumption (8, 10, 11, 26) and have reported mixed results.  However, our study is 
different from these previous works in that we concentrate on the sigmoid colon and rectum.  
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It is possible that the proximal areas of the colon are not affected by trans fatty acid 
consumption whereas the more distal sections are.  Potentially, prior studies that combined 
cancers of colon and rectum into one outcome group would not have seen a positive 
association between colorectal cancer and trans fatty acid consumption if the majority of 
cases in their study were comprised of individuals with cancers of the proximal colon.  The 
incidence of rectal cancer is much lower than that of colon cancer so it is possible that 
relatively few distal colorectal cancers were included in previous studies.     
There are several potential mechanisms by which trans fatty acid consumption could 
affect the risk of distal colorectal cancer.  First, trans fatty acids themselves could irritate the 
colonic mucosa.  A study in male rats found that the fat excretion:intake ratio was two times 
higher for rats fed trans fatty acid compared to rats fed cis- fatty acids (29).  Though to our 
knowledge no similar studies have been performed in humans,   it is possible that trans fatty 
acids present in fecal matter irritate the distal colon and rectum, resulting in increased 
proliferation, inflammation and, oxidative stress.  A higher amount of an oxidative stress 
marker (urinary 8-iso-PGF(2alpha)) was found in participants of a small randomized trial 
who consumed 6.0 grams of trans fatty acid per day for six weeks when compared with 
those given a diet free of trans fatty acids over the same time period (30).  In addition, 
systemic inflammatory markers [soluble tumor necrosis factor α receptor 1 and 2 (sTNF-R1 
and –R2)] have been positively associated with trans fatty acid intake in women from the 
Nurses’ Health Study cohort (28).  Bile acids resulting from the digestion of trans fatty acids 
may also play a role.  Some studies have shown that bile acids in the colon are metabolized 
by bacteria, producing carcinogenic compounds and increasing cellular proliferation (31, 
32). Another mechanism explaining the roles of trans fatty acids in the development of 
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distal colorectal cancer could be that of insulin resistance.  Studies have found that trans 
fatty acid intake increased insulin resistance in subjects with diabetes or insulin resistance, 
though this effect was not seen in healthy subjects (33).  Increased insulin stimulates cell 
signaling pathways to increase proliferation, which will favor cells that are defective (such 
as those with activated oncogenes) (34).  Cellular proliferation has been positively 
associated with the incidence of colorectal cancer in animals (35).   
 Currently, there is a campaign to have trans fatty acids removed from foods.  Certain 
localities, including New York City, have banned trans fatty acids from commercial food 
outlets (36, 37).  As of January 1, 2006, all food products sold in the United States were 
required to list the amount of trans fatty acids in the nutritional information on packaging 
(38).  Though we did not stop enrollment until August of 2006, we do not believe that the 
removal and labeling of foods affected our results.  First, it is not consumption immediately 
prior to the development of cancer that is likely to be the most important, so diet during this 
period of eight months is not likely to have resulted in immediate cancer.  Also, the 
Diet*Calc system uses trans fatty acid values for foods prior to January 2006 (when many 
companies began removing them from their foods) so the amount of trans fatty acids in the 
food supply matches that of the amount we assigned to each food participants reported 
consuming.   
 This study has certain strengths.  The study was large, population-based, and used 
dietary instruments previously validated in other populations (23).  The interviews were 
conducted in-person and captured information on various potential colorectal cancer risk 
factors.  There are some limitations as well.  First, although there were a large number of 
White participants the number of African Americans in our study population was small.  As 
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in all case-control study designs, there is the potential for selection and recall bias.  Also, our 
food frequency questionnaire grouped all foods of a certain type together.  The amount of 
trans fatty acids vary within each type of food based on the brand, preparation, etc.  Thus, 
we were unable to discern if people eating certain foods had more or less trans fatty acids in 
their diet than people eating different brands of a similar food.   
 In conclusion, we have demonstrated that increased consumption of trans fatty acid 
is associated with an increased risk of cancers in the sigmoid colon, rectosigmoid, and 
rectum in Whites.  The results for African Americans are inconclusive but in our study 
population distal colorectal cancer appeared to be inversely associated with trans fatty acid 
consumption.  This research contributes to the growing literature supporting negative health 
effects of trans fatty acid.  Reductions in consumption of trans fatty acids and their removal 
from foods should be advocated.   
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6.6 TABLES 
 
 
 
 
TABLE 6.1.  Characteristics of the North Carolina Colon Cancer Study II (NCCCS II) 
population by case status and race, NC, 2001-2006 
Participant Characteristics Whites (n=1516) African-Americans (n=392) 
  Cases  
(n=717) 
Controls 
(n=799) 
Cases 
 (n=233) 
Controls 
(n=159) 
Age (%)     
 <50 87 (12.13) 74 (9.26) 32 (13.73) 17 (10.69) 
 50-59 193 (26.92) 183 (22.90) 68 (29.18) 41 (25.79) 
 60-69 211 (29.43) 253 (31.66) 79 (33.91) 54 (33.96) 
 >70 years 226 (31.52) 289 (36.17) 54 (23.18) 47 (29.56) 
 Mean years (SD) 62.7 (10.1) 64.1 (9.8) 61.3 (9.9) 63.2 (9.6) 
Sex (%)     
 Men 410 (57.18) 483 (60.45) 118 (50.64) 84 (52.83) 
 Women 307 (42.82) 316 (39.55) 115 (49.36) 75 (47.17) 
Education (%)     
 ≤ High School 139 (19.39) 97 (12.14) 82 (35.19) 42 (26.42) 
 Some college 369 (51.46) 372 (46.56) 100 (42.92) 81 (50.94) 
 College graduate/advanced 
degree 
209 (29.15) 330 (41.30) 51 (21.89) 36 (22.64) 
Body Mass Index 1 year prior to 
enrollment (%)* 
    
 Normal (18-24.9 kg/m2) 171 (24.68) 246 (31.62) 41 (18.98) 33 (22.00) 
 Overweight (25-29.9 kg/m2) 268 (38.67) 312 (40.10) 68 (31.48) 55 (36.67) 
 Obese (>=30 kg/m2) 254 (36.65) 220 (28.28) 107 (49.54) 62 (41.33) 
 Mean  kg/m2 (SD) 29.1 (6.3) 28.0 (5.5) 31.6 (7.8) 29.8 (6.5) 
Physical Activity (MET-
minutes/day) (mean, %)*     
 1st quartile 176 (25.69) 186 (24.35) 66 (30.84) 42 (28.77) 
 2nd quartile 168 (24.53) 183 (23.95) 54 (25.23) 44 (30.14) 
 3rd quartile 138 (20.15) 201 (26.31) 36 (16.82) 27 (18.49) 
 4th quartile 203 (29.64) 194 (25.39) 58 (27.10) 33 (22.60) 
 Mean MET-minutes/day (SD) 2249.7 (664.3) 2152.6 (475.0) 2172.5 (540.0) 2148.9 (495.0) 
Smoking status (%)     
 Never 264 (36.87) 301 (37.96) 87 (38.50) 62 (40.00) 
 Former 342 (47.77) 386 (48.68) 87 (38.50) 67 (43.23) 
 Current 110 (15.36) 106 (13.37) 52 (23.01) 26 (16.77) 
Family History (%)     
 Yes 92 (13.16) 89 (11.37) 27 (11.84) 8 (5.16) 
 No 607 (86.84) 694 (88.63) 201 (88.16) 147 (94.84) 
NSAID use over the past 5 years 
(%)*†     
 Never 160 (22.32) 120 (15.02) 65 (28.76) 39 (25.32) 
 Occasionally 307 (42.82) 315 (39.42) 105 (46.46) 79 (51.30) 
 Regularly 250 (34.87) 364 (45.56) 56 (24.78) 36 (23.38) 
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Trans Fat Consumption     
 Mean grams (SD) 6.05 (3.03) 5.41 (2.88) 6.32 (3.31) 6.34 (3.53) 
Total Energy Intake      
 Mean kcal (SD) 2248.1 (822.4) 2147.5 (793.9) 2389.5 (944.6) 2210.5 (907.4) 
Calcium Consumption      
 Mean grams (SD) 816.9 (359.1) 859.4 (393.3) 779.7 (350.7) 725.5 (359.6) 
Alcohol Consumption      
 0 drinks/day 366 (51.05) 320 (40.04) 156 (66.95) 97 (61.01) 
 >0 and <1 drink/day 219 (30.54) 315 (39.42) 45 (19.31) 45 (28.30) 
 ≥1 drink/day 132 (18.41) 164 (20.53) 32 (13.73) 17 (10.69) 
Red Meat Consumption      
 Mean ounces (SD) 1.9 (1.4) 1.8 (1.4) 1.8 (1.5) 1.8 (1.6) 
Vegetable Consumption     
 Mean servings (SD) 4.1 (2.0) 4.3 (2.1) 4.1 (2.3) 3.8 (2.3) 
*Data were missing for: BMI (n=71), physical activity (n=99), smoking status (n=18), family history (n=43)  
and NSAID use (n=12) 
† NSAID use is defined as Never for subjects who reported no use, Occasional for subjects who reported some  
use but use<15 times/month, and Frequent for subjects who reported use of NSAIDs at least 15 
times/month
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TABLE 6.2. Odds ratios (95% confidence intervals)*† of quartiles of trans fatty acid intake with distal colorectal cancer by race (n=1908),  
NCCCS II, 2001-2006 
Quartiles of intake  Total Study Population (n=1908)‡  Whites (n=1516)  African-Americans (n=392) 
   
TOTAL TRANS FATTY ACID CONSUMPTION     
 Median grams of 
trans fatty acid 
/day (IQR) 
No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI 
Q1 4.40 (3.70, 4.84) 199 240 1.00   146 216 1.00   53 24 1.00  
Q2 5.66 (5.41, 5.92) 214 239 1.10 0.83, 1.46  154 203 1.12 0.81, 1.54  60 36 0.89 0.44, 1.77 
Q3 6.65 (6.39, 6.91) 267 240 1.31 0.99, 1.74  213 198 1.45 1.06, 1.97  54 42 0.72 0.36, 1.43 
Q4 8.30 (7.73, 9.29) 270 239 1.14  0.87, 1.51  204 182 1.34 0.99, 1.83  66 57 0.54 0.28, 1.02 
16:1 TRANS HEXADECENOIC FATTY ACID CONSUMPTION 
 Median grams of 
trans fatty acid 
/day (IQR) 
No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI 
Q1 0.05 (0.04, 0.06) 234 240 1.00   167 211 1.00   67 29 1.00  
Q2 0.07 (0.07, 0.08) 210 239 1.01 0.77, 1.33  162 203 1.05 0.78, 1.43  48 36 0.80 0.41, 1.58 
Q3 0.09 (0.08, 0.10) 222 240 1.03 0.78, 1.37  169 202 1.10 0.80, 1.50  53 38 0.72 0.37, 1.41 
Q4 0.13 (0.11, 0.16) 284 239 1.20 0.92, 1.56  219 183 1.45 1.08, 1.94  65 56 0.57 0.31, 1.04 
18:1 TRANS OCTADECENOIC FATTY ACID CONSUMPTION 
 Median grams of 
trans fatty acid 
/day (IQR) 
No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI 
Q1 3.77 (3.20, 4.16) 208 240 1.00   153 215 1.00   55 25 1.00  
Q2 4.99 (4.65, 5.10) 206 239 0.99 0.75, 1.32  149 204 1.00 0.73, 1.37  57 35 0.84 0.42, 1.68 
Q3 5.77 (5.55, 6.03) 264 240 1.22 0.93, 1.61  210 200 1.31 0.96, 1.78  54 40 0.75 0.38, 1.48 
Q4 7.28 (6.76, 8.21) 272 239 1.08 0.82, 1.42  205 180 1.27 0.93, 1.73  67 59 0.51 0.27, 0.95 
18:2 TRANS OCTADECADIENOIC FATTY ACID CONSUMPTION 
 Median grams of 
trans fatty acid 
/day (IQR) 
No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI  No. of 
cases 
No. of 
controls 
OR 95% CI 
Q1 0.52 (0.44, 0.56) 207 240 1.00   143 210 1.00   64 30 1.00  
Q2 0.64 (0.62, 0.66) 206 239 1.08 0.81, 1.43  150 201 1.11 0.81, 1.53  56 38 0.91 0.48, 1.74 
Q3 0.74 (0.71, 0.77) 257 240 1.21 0.92, 1.60  202 197 1.35 0.99, 1.85  55 43 0.72 0.38, 1.38 
Q4 0.89 (0.84, 0.97) 280 239 1.18 0.90, 1.55  222 191 1.38 1.02, 1.88  58 48 0.60 0.32, 1.11 
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*OR: odds ratio; 95%CI: 95% Confidence Interval, IQR: Interquartile range 
† Adjusted for energy intake, age, sex, BMI 1 year prior, highest level of education attained, family history of colorectal cancer, and race (in the combined 
estimates) 
‡Likelihood ratio tests of odds ratio modification by race gave the following results: Total trans fatty acid intake 0.02; 16:1 Trans fatty acid intake 0.08; 18:1 
Trans fatty acid intake 0.02; 18:2 Trans fatty acid intake 0.03 
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TABLE 6.3.  Adjusted odds ratios (95% confidence intervals)*† of quartiles of trans fatty acid intake with cancer risk by race and 
location, NCCCS II, 2001-2006 
 Whites  African-Americans 
 
RECTUM 
Quartiles of intake No. of cases No. of controls OR 95% CI  No. of cases No. of controls OR 95% CI 
Q1‡ 48 191 1.00   13 21 1.00  
Q2‡ 52 194 1.15 0.72, 1.86  25 34 2.09 0.76, 5.75 
Q3‡ 71 175 1.56 0.98, 2.25  11 36 0.77 0.26, 2.30 
Q4‡ 68 164 1.32 0.82, 2.11  18 47 0.68 0.25, 1.81 
 
SIGMOID 
Quartiles of intake No. of cases No. of controls OR 95% CI  No. of cases No. of controls OR 95% CI 
Q1‡ 52 191 1.00   26 21 1.00  
Q2‡ 63 194 1.04 0.66, 1.63  23 34 0.59 0.24, 1.46 
Q3‡ 84 175 1.35 0.87, 2.11  30 36 0.96 0.40, 2.33 
Q4‡ 80 164 1.25 0.80, 1.97  27 47 0.51 0.22, 1.18 
 
RECTOSIGMOID 
Quartiles of intake No. of cases No. of controls OR 95% CI  No. of cases No. of controls OR 95% CI 
Q1‡ 25 191 1.00   4 21 1.00  
Q2‡ 23 194 1.01 0.52, 1.95  3 34 0.53 0.09, 3.11 
Q3‡ 34 175 1.63 0.87, 3.07  6 36 1.17 0.26, 5.35 
Q4‡ 34 164 1.31 0.70, 2.43  11 47 1.17 0.29, 4.72 
*OR: odds ratio; 95%CI: 95% Confidence Interval 
†Adjusted for energy intake, age, sex, BMI 1 year prior, highest level of education attained, family history of colorectal cancer, 
smoking status, meat consumption, calcium intake, and physical activity 
‡Median trans fatty acid intake grams/day (IQR): Q1) 4.40 (3.70, 4.84); Q2) 5.66 (5.41, 5.92); Q3) 6.65 (6.39, 6.91);  
            Q4) 8.30 (7.73, 9.29) 
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 7. CONCLUSIONS 
 
7.1 RECAPITULATION OF STUDY AIMS AND FINDINGS 
 
 The goal of this dissertation was to explore the relationship between trans fatty acid 
consumption and digestive tract neoplasia.  Through the use of three large studies, each of 
the proposed aims was investigated.  These aims were: to determine whether increasing 
consumption of trans fatty acids is associated with 1) colorectal adenomas (adenomas 
present throughout the entire colon and rectum); 2) colon cancer (cancers from the cecum 
through the sigmoid colon); and 3) distal colorectal cancer (cancers of the sigmoid colon, 
rectosigmoid, and rectum).  No relationship was present between colon cancer and trans 
fatty acid consumption, but a positive association was detected with increasing consumption 
for colorectal adenomas and distal colorectal cancer (in Whites).  The findings regarding 
each of the three aims are further summarized below.   
 
 
7.1.1 TRANS FATTY ACID CONSUMPTION AND COLORECTAL ADENOMAS 
 Using the Diet and Health Study IV, the relationship between trans fatty acid 
consumption and the prevalence of colorectal adenomas (adenomas present throughout the 
entire colon and rectum) was examined.  High consumption was associated with colorectal 
adenomas, but lower levels of consumption did not show an association.  Associations 
between trans fatty acid consumption and location, size, and number of adenomas were 
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imprecise, but were consistently elevated for the highest versus lowest quartiles of 
consumption.  A strong association was present in the proximal versus distal colon; 
however, a difference in the association by location could not be firmly established due to 
the precision of the estimates.  There was no difference in the relationship between 
colorectal adenomas and trans fatty acid consumption by size or number of adenomas.
 
7.1.2 TRANS FATTY ACID CONSUMPTION AND COLON CANCER 
 The second aim of this dissertation was to explore the relationship between trans 
fatty acid consumption and colon cancer (cancers present throughout the colon from the 
cecum through the sigmoid colon).  In this study, trans fatty acid consumption was not 
associated with the risk of colon cancer among Whites or African Americans.  Furthermore, 
the association did not vary by cancer location.   
 This study went further than proposed by examining the association by race, with the 
possibility that differential consumption of trans fatty acids might explain some of the 
disparity in colon cancer rates between Whites and African Americans.  Based on the similar 
consumption patterns and the lack of association seen in this study, it is unlikely that trans 
fatty acid consumption is contributing to the disparity in colon cancer rates between Whites 
and African Americans.   
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7.1.3 TRANS FATTY ACID CONSUMPTION AND DISTAL  
COLORECTAL CANCER 
 
 The third aim looked at the relationship between trans fatty acid consumption and 
colorectal cancer but this time concentrated on distal colorectal cancer (cancer of the 
sigmoid colon, rectosigmoid, or rectum).  Increasing consumption of trans fatty acids was 
positively associated with distal colorectal cancer in Whites.  This relationship was the 
opposite for African Americans, with increased consumption resulting in an inverse 
association.   
 Recent studies have shown that cancers of the colon and rectum may have different 
risk factors (1-3).  The results of this aim combined with that of the previous aim support the 
conclusion that trans fatty acid consumption may be another risk factor that is different for 
the colon and the rectum.  High consumption of trans fatty acids may be a risk factor for 
cancers of the sigmoid colon, rectosigmoid, and rectum but not a risk factor for colon 
cancer.   
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7.2 STRENGTHS 
 
 One of the key strengths of this research was the opportunity to utilize data on three 
different aspects of colorectal neoplasia.  The association between trans fatty acid 
consumption and colorectal neoplasia was examined for different stages in the 
carcinogenesis process (adenoma and cancer), as well as varying locations of cancer (colon 
versus distal colon/rectum).  Moreover, previous studies have not examined the association 
within a large sample of African Americans as was possible in the NCCCS I.   
 All of the studies utilized included a large number of participants and had good 
response rates.  In addition, data was collected by trained interviewers in all three studies.  
The interviews were in-depth and covered a wide range of information on potential risk 
factors.  The food frequency questionnaires that were utilized have been previously 
validated in other study populations (4-6).   
 Finally, effort was taken to reduce the misclassification of cases as controls.  In the 
DHS IV study, a study pathologist reviewed every slide and a random sample of all biopsies 
collected was resubmitted for review, which found there to be high concordance among the 
classifications.  For the NCCCSs I and II, all of the diagnoses were confirmed by the study 
pathologist using pathology reports and over 95% of the diagnoses were confirmed using the 
pathology slides.   
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7.3 LIMITATIONS 
 
 As is the case for all case-control studies as well as some cross-sectional studies, our 
studies are subject to selection and recall biases.  Selection bias occurs when individuals 
who choose to participate in the study are different than the individuals who refuse to be a 
part of the study.  In other words, the cases and controls that were recruited for the NCCCSs 
I and II and DHS IV may be different from the actual participants of the studies.  However, 
high response rates among both cases and controls minimized the amount of selection bias 
present in the studies.  Selection bias could also occur if subjects are recruited for the study 
in a nonrandomized fashion.  The NCCCSs I and II both used randomized recruitment 
strategies as explained in the Methods section (Chapter 3).  In the DHS IV, almost every 
eligible individual undergoing a colonoscopy during the study period was recruited.  The 
recruitment methods used in all three of these studies greatly reduced the possibility of 
selection bias resulting from nonrandomized participant selection.  Recall bias is a type of 
information bias that occurs when cases and controls remember their exposure differently 
due to their knowledge of case-control status.  For example, cases may have believed that 
poor dietary habits resulted in their development of adenomas/cancer.  Therefore, they 
recalled consumption of unhealthy foods, such as those containing trans fatty acids, more 
readily than would controls who are not searching for an explanation to a health problem.  
However, due to the lack of previous research, it is unlikely that cases believed their cancers 
to be caused specifically by trans fatty acid consumption.  Consequently, it is not expected 
that cases would disproportionately recall foods with high amounts of trans fatty acids.   
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In addition, because the NCCCSs I and II are case-control studies and we inquire 
about diet only one year prior to diagnosis, we cannot establish temporality between trans 
fatty acid consumption and distal colorectal cancer; we can only detect the presence of an 
association.  This issue of temporality is also present in the DHS IV.  Only an association 
can be determined between trans fatty acid consumption and colorectal adenomas.   
None of the food frequency questionnaires that we utilized in these studies have been 
validated for trans fatty acid intake.  Also, we had to assign the values for trans fatty acid to 
each food present in the Block Food Frequency Questionnaire.  As discussed in the Results 
section (Chapter 5), this was a problem for certain options, such as “restaurant fried 
chicken” versus “homemade fried chicken” since we did not have values that differed in 
regards to where the food was eaten.  Most likely, this did not affect the results as it was a 
small number of foods contributing to only a minor portion of participants’ reported diets.  
One problem that was present in all of the studies was that the food frequency questionnaires 
did not ask participants about the brands of food that they consumed.  Different brands 
contain varying amounts of trans fatty acids and we were unable to distinguish between 
participants that consumed brands with high amounts of trans fatty acids from participants 
eating similar foods with lower amounts of trans fatty acids.  Finally, trans fatty acid 
consumption could be acting as a proxy for other unhealthy behaviors.  We attempted to 
control for this by including covariates that would also be indicative of unhealthy behaviors, 
such as alcohol consumption, physical activity, and BMI, when determining what 
confounders should remain in the final models of each study.    
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7.4 PUBLIC HEALTH SIGNIFICANCE 
 
 Colorectal cancer is the third leading cause of cancer death among men and women 
in the United States.  It is also the third most commonly diagnosed cancer in the United 
States (7).  Various aspects of diet are known to be associated with colorectal cancer (8, 9, 
10).  Diet is a modifiable risk factor, which allows individuals and policies to change in 
order to reduce the rates of colorectal cancer.   
 Thus far, few studies have examined the association between colorectal neoplasia 
and trans fatty acid consumption.  However, due to the strong association found between 
trans fatty acid consumption and cardiovascular disease, there is already a strong push to 
have them removed from the food supply.  Certain localities, including New York City, have 
banned trans fatty acids from commercial food outlets (11, 12), and as of January 1, 2006, 
all food products sold in the United States were required to list the amount of trans fatty 
acids in the nutritional information on packaging (13).  Activist groups in the United States 
have also taken action by suing corporations such as McDonald’s and Kraft to have them 
remove the trans fatty acids from their foods (14).   
 High trans fatty acid consumption was associated with colorectal adenomas in our 
study population.  Through one or more of the biologic mechanisms proposed in Chapter 
1.2.3 (Background Section on Trans Fatty Acids) high consumption of trans fatty acids 
increased the relative risk for colorectal adenoma.  Though adenomas are the precursors to 
cancer, increased consumption of trans fatty acids was not associated with cancer in all 
areas of the colon.  The association between trans fatty acid consumption and colorectal 
cancer was limited to cancers of the sigmoid colon, rectosigmoid, and rectum.  In these 
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distal areas, high trans fatty acid consumption increased the relative risk of cancer among 
Whites in our study population.  An inverse association was detected for trans fatty acid 
consumption and cancer in these distal areas of the colon for African Americans in our study 
population, but further research needs to be done with a large sample of African Americans 
to elucidate if this association exists in other populations of African Americans or if it is the 
result of bias present in our study.   
 The results of this dissertation provide further support to campaigns whose goal is to 
limit the amount of trans fatty acids present in the food supply and to recommendations for 
individuals to reduce their intake of trans fatty acids.  As consumption of trans fatty acids 
continues to decline in the United States, it is expected that rates of colorectal adenomas and 
cancer may fall as well.   
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